# EDGAR Filing Document

**Accession Number:** 0000861842
**File Stem:** 0001437749-26-015940
**Filing Date:** 2026-5
**Character Count:** 219922
**Document Hash:** 1323dc880f01ae5cb43debd6cb3ea517
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001437749-26-015940.hdr.sgml**: 20260508

**ACCESSION NUMBER**: 0001437749-26-015940

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 92

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260508

**DATE AS OF CHANGE**: 20260508

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CATHAY GENERAL BANCORP
- **CENTRAL INDEX KEY:** 0000861842
- **STANDARD INDUSTRIAL CLASSIFICATION:** STATE COMMERCIAL BANKS [6022]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 954274680
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-31830
- **FILM NUMBER:** 26959369

**BUSINESS ADDRESS:**
- **STREET 1:** 777 N BROADWAY
- **CITY:** LOS ANGELES
- **STATE:** CA
- **ZIP:** 90012
- **BUSINESS PHONE:** 2136254700

**MAIL ADDRESS:**
- **STREET 1:** 777 NORTH BROADWAY
- **CITY:** LOS ANGELES
- **STATE:** CA
- **ZIP:** 90012

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CATHAY BANCORP INC
- **DATE OF NAME CHANGE:** 19930328

?xml version='1.0' encoding='ASCII'? caty20260331c_10q.htm

[**Table of Contents**](#toc)

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

Washington, D.C. 20549

**FORM 10-Q**

(Mark One)

**☒** **QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

---

| | |
|:---|:---|
| For the quarterly period ended | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;March 31, 2026 |

---

**OR**

**☐** **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934**

---

| | |
|:---|:---|
| For the transition period from | to |

---

---

| | |
|:---|:---|
| Commission file number | 001-31830 |

---

CATHAY GENERAL BANCORP

------

(Exact name of registrant as specified in its charter)

---

| | |
|:---|:---|
| Delaware | 95-4274680 |
| (State of other jurisdiction of incorporation<br> or organization) | (I.R.S. Employer<br> Identification No.) |

---

---

| | |
|:---|:---|
| 777 North Broadway, Los Angeles, California | 90012 |
| (Address of principal executive offices) | Zip Code) |

---

---

| | |
|:---|:---|
| Registrant's telephone number, including area code: | (213) 625-4700 |

---

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| Title of each class | Trading Symbol | Name of each exchange on which registered |
| Common Stock | CATY | Nasdaq Global Select Market |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Large accelerated filer ☒ |  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Accelerated filer ☐ |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-accelerated filer ☐ | Smaller reporting company ☐ | Emerging growth company ☐ |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; No ☒

Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date.

Common stock, $0.01 par value, 67,035,475 shares outstanding as of April 30, 2026.

------

[**Table of Contents**](#toc)

 **CATHAY GENERAL BANCORP AND SUBSIDIARIES**

**1ST QUARTER 2026 REPORT ON FORM 10-Q**

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
| [<u>PART I</u> <u>–</u> <u>FINANCIAL INFORMATION</u>](#part1) | [<u>PART I</u> <u>–</u> <u>FINANCIAL INFORMATION</u>](#part1) | [2](#part1) |
| &nbsp;&nbsp;&nbsp;Item 1. | [<u>FINANCIAL STATEMENTS (Unaudited)</u>](#part1) | [2](#part1) |
|  | [<u>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)</u>](#notes) | [6](#notes) |
| &nbsp;&nbsp;&nbsp;Item 2. | [<u>MANAGEMENT</u><u>'</u><u>S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</u>](#mda) | [25](#mda) |
| &nbsp;&nbsp;&nbsp;Item 3. | [<u>QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</u>](#qqd) | [36](#qqd) |
| &nbsp;&nbsp;&nbsp;Item 4. | [<u>CONTROLS AND PROCEDURES</u>](#cp) | [37](#cp) |
| [<u>PART II</u> <u>–</u> <u>OTHER INFORMATION</u>](#part2) | [<u>PART II</u> <u>–</u> <u>OTHER INFORMATION</u>](#part2) | [38](#part2) |
| &nbsp;&nbsp;&nbsp;Item 1. | [<u>LEGAL PROCEEDINGS</u>](#lp) | [38](#lp) |
| &nbsp;&nbsp;&nbsp;Item 1A. | [<u>RISK FACTORS</u>](#rf) | [38](#rf) |
| &nbsp;&nbsp;&nbsp;Item 2. | [UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS](#uses) | [38](#uses) |
| &nbsp;&nbsp;&nbsp;Item 3. | [<u>DEFAULTS UPON SENIOR SECURITIES</u>](#dss) | [38](#dss) |
| &nbsp;&nbsp;&nbsp;Item 4. | [<u>MINE SAFETY DISCLOSURES</u>](#msd) | [38](#msd) |
| &nbsp;&nbsp;&nbsp;Item 5. | [<u>OTHER INFORMATION</u>](#oi) | [38](#oi) |
| &nbsp;&nbsp;&nbsp;Item 6. | [<u>EXHIBITS</u>](#ex) | [39](#ex) |
| &nbsp;&nbsp;&nbsp;[<u>SIGNATURES</u>](#sigs) | &nbsp;&nbsp;&nbsp;[<u>SIGNATURES</u>](#sigs) | [40](#sigs) |

---

------

[**Table of Contents**](#toc)

**Forward-Looking Statements**

In this Quarterly Report on Form 10-Q, the term "Bancorp" refers to Cathay General Bancorp and the term "Bank" refers to Cathay Bank. The terms "Company," "we," "us," and "our" refer to Bancorp and the Bank collectively.

The statements in this report include forward-looking statements within the meaning of the applicable provisions of the Private Securities Litigation Reform Act of 1995 regarding management's beliefs, projections, and assumptions concerning future results and events. We intend such forward-looking statements to be covered by the safe harbor provision for forward-looking statements in these provisions. All statements other than statements of historical fact are "forward-looking statements" for purposes of federal and state securities laws, including statements about anticipated future operating and financial performance, financial position and liquidity, growth opportunities and growth rates, growth plans, acquisition and divestiture opportunities, business prospects, strategic alternatives, business strategies, financial expectations, regulatory and competitive outlook, loan and deposit growth, investment and expenditure plans, financing needs and availability, level of nonperforming assets, and other similar forecasts and statements of expectation and statements of assumptions underlying any of the foregoing. Words such as "aims," "anticipates," "believes," "can," "continue," "could," "estimates," "expects," "hopes," "intends," "may," "optimistic," "plans," "potential," "possible," "predicts," "projects," "seeks," "shall," "should," "will," and variations of these words and similar expressions are intended to identify these forward-looking statements. Forward-looking statements by us are based on estimates, beliefs, projections, and assumptions of management and are not guarantees of future performance. These forward-looking statements are subject to certain risks, uncertainties and other factors that could cause actual results to differ materially from our historical experience and our present expectations or projections. Such risks, uncertainties and other factors include, but are not limited to:

● local, regional, national and international economic and market conditions and events and the impact they may have on us, our clients and our operations, assets and liabilities;

● possible additional provisions for loan losses and charge-offs;

● credit risks of lending activities and deterioration in asset or credit quality;

● extensive laws and regulations and supervision that we are subject to, including potential supervisory action by bank supervisory authorities;

● increased costs of compliance and other risks associated with changes in regulation;

● higher capital requirements from the implementation of the Basel III capital standards;

● compliance with the Bank Secrecy Act and other money laundering statutes and regulations;

● potential goodwill impairment;

● liquidity risk;

● fluctuations in interest rates;

● risks associated with acquisitions and the expansion of our business into new markets;

● inflation and deflation;

● real estate market conditions and the value of real estate collateral;

● environmental liabilities;

● our ability to generate anticipated returns from our investments and/or financings in certain tax advantaged-projects;

● our ability to compete with larger competitors;

● our ability to retain key personnel;

● successful management of reputational risk;

● natural disasters, public health crises (including the occurrence of a contagious disease or illness) and geopolitical events (including wars and armed conflicts);

● potential for new or increased tariffs or trade restrictions;

● failures, interruptions, or security breaches of our information systems;

● our ability to adapt our systems to the expanding use of technology in banking;

● risk management processes and strategies;

● adverse results in legal proceedings;

● the impact of regulatory enforcement actions, if any;

● certain provisions in our charter and bylaws that may affect acquisition of the Company;

● changes in accounting standards or tax laws and regulations;

● market disruption and volatility;

● fluctuations in the Bancorp's stock price;

● restrictions on dividends and other distributions by laws and regulations and by our regulators and our capital structure;

● issuances of preferred stock;

● capital level requirements and successfully raising additional capital, if needed, and the resulting dilution of interests of holders of Bancorp common stock; and

● the soundness of other financial institutions.

These and other factors are further described in Bancorp's Annual Report on Form 10-K for the year ended December 31, 2025 (Item 1A in particular), other reports and registration statements filed with the Securities and Exchange Commission ("SEC"), and other filings Bancorp makes with the SEC from time to time. Actual results in any future period may also vary from the past results discussed in this report. Given these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements. We have no intention and undertake no obligation to update any forward-looking statement or to announce publicly any revision of any forward-looking statement to reflect developments, events, occurrences or circumstances after the date of such statement, except as required by law.

Bancorp's filings with the SEC are available at the website maintained by the SEC at http://www.sec.gov, or by request directed to Cathay General Bancorp, 9650 Flair Drive, El Monte, California 91731, Attention: Investor Relations (626) 279-3296.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1

------

[**Table of Contents**](#toc)

 **PART I** – **FINANCIAL INFORMATION**

**Item 1. FINANCIAL STATEMENTS (Unaudited)**

**CATHAY GENERAL BANCORP AND SUBSIDIARIES**

**CONSOLIDATED BALANCE SHEETS**

(Unaudited)

---

| | | |
|:---|:---|:---|
| ($ In thousands, except par value and share data) | ***March 31, 2026*** | ***December 31, 2025*** |
| **Assets** |  |  |
| Cash and due from banks | $135540 | $146320 |
| Short-term investments and interest-bearing deposits | 1069943 | 1278089 |
| Securities available-for-sale at fair value (amortized cost of $1,740,858 at March 31, 2026, and $1,735,451 at December 31, 2025) | 1678140 | 1658223 |
| Loans held for sale | 6902 |  |
| Loans held for investment | 20174589 | 20147202 |
| Less: Allowance for loan losses | (208786) | (195911) |
| Unamortized deferred loan fees, net | (14164) | (14903) |
| Loans held for investment, net | 19951639 | 19936388 |
| Equity securities (fair value of $26,617 at March 31, 2026, and $32,754 at December 31, 2025) | 69202 | 51886 |
| Federal Home Loan Bank stock | 17250 | 17250 |
| Other real estate owned, net | 33436 | 30336 |
| Affordable housing investments and alternative energy partnerships, net | 287283 | 287182 |
| Premises and equipment, net | 88464 | 87579 |
| Customers' liability on acceptances | 5409 | 4385 |
| Accrued interest receivable | 94570 | 96993 |
| Goodwill | 375696 | 375696 |
| Other intangible assets, net | 2450 | 2683 |
| Right-of-use assets - operating leases | 34737 | 34187 |
| Other assets | 197969 | 222378 |
| **Total assets** | $**24048630** | $**24229575** |
| **Liabilities and Stockholders' Equity** |  |  |
| Deposits: |  |  |
| Non-interest-bearing | $3399461 | $3505606 |
| Interest-bearing: |  |  |
| NOW deposits | 2336121 | 2370047 |
| Money market deposits | 3701873 | 3800471 |
| Savings deposits | 1518300 | 1500890 |
| Time deposits | 9719892 | 9717153 |
| Total deposits | 20675647 | 20894167 |
| Long-term debt | 119136 | 119136 |
| Acceptances outstanding | 5409 | 4385 |
| Lease liabilities - operating leases | 36581 | 36102 |
| Other liabilities | 225209 | 250397 |
| **Total liabilities** | 21061982 | 21304187 |
| Commitments and contingencies |  |  |
| **Stockholders' Equity** |  |  |
| Common stock, $0.01 par value, 100,000,000 shares authorized; 91,818,560 issued and 66,972,039 outstanding at March 31, 2026, and 91,803,148 issued and 67,200,126 outstanding at December 31, 2025 | 918 | 918 |
| Additional paid-in-capital | 1003609 | 1001401 |
| Accumulated other comprehensive loss, net | (44178) | (54400) |
| Retained earnings | 2971119 | 2909677 |
| Treasury stock, at cost (24,846,521 shares at March 31, 2026, and 24,603,022 shares at December 31, 2025) | (944820) | (932208) |
| **Total stockholders' equity** | 2986648 | 2925388 |
| **Total liabilities and stockholders' equity** | $**24048630** | $**24229575** |

---

See accompanying Notes to Consolidated Financial Statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2

------

[**Table of Contents**](#toc)

**CATHAY GENERAL BANCORP AND SUBSIDIARIES**

**CONSOLIDATED STATEMENTS OF OPERATIONS AND**

**COMPREHENSIVE INCOME**

(Unaudited)

---

| | | |
|:---|:---|:---|
|  | ***Three Months Ended March 31,*** | ***Three Months Ended March 31,*** |
| ($ In thousands, except share and per share data) | *2026* | *2025* |
| **Interest and Dividend Income** |  |  |
| Loans receivable | $298935 | $293984 |
| Investment securities | 12983 | 12103 |
| Federal Home Loan Bank stock | 874 | 379 |
| Deposits with banks | 10118 | 12929 |
| Total interest and dividend income | 322910 | 319395 |
| **Interest Expense** |  |  |
| Time deposits | 84846 | 96066 |
| Other deposits | 41006 | 42434 |
| Advances from Federal Home Loan Bank | 1010 | 1904 |
| Long-term debt | 1829 | 2020 |
| Short-term debt | 51 | 332 |
| Total interest expense | 128742 | 142756 |
| Net interest income before provision for credit losses | 194168 | 176639 |
| Provision for credit losses | 18193 | 15500 |
| Net interest income after provision for credit losses | 175975 | 161139 |
| **Non-Interest Income** |  |  |
| Net gains/(losses) from equity securities | 17316 | (4191) |
| Impairment loss on investment securities | (15685) |  |
| Letters of credit commissions | 2406 | 2091 |
| Depository service fees | 2014 | 1752 |
| Wealth management fees | 7102 | 6169 |
| Other operating income | 7506 | 5383 |
| Total non-interest income | 20659 | 11204 |
| **Non-Interest Expense** |  |  |
| Salaries and employee benefits | 45511 | 42427 |
| Occupancy expense | 5816 | 5737 |
| Computer and equipment expense | 5627 | 6054 |
| Professional services expense | 7782 | 7448 |
| Data processing service expense | 4015 | 4406 |
| FDIC and regulatory assessments | 2447 | 3399 |
| Marketing expense | 1863 | 1878 |
| Other real estate owned expense | 1589 | 244 |
| Amortization of investments in low-income housing and alternative energy partnerships | 6740 | 9054 |
| Amortization of core deposit intangibles | 218 | 250 |
| Other operating expense | 5072 | 4759 |
| Total non-interest expense | 86680 | 85656 |
| **Income before income tax expense** | 109954 | 86687 |
| Income tax expense | 23068 | 17181 |
| **Net income** | $**86886** | $**69506** |
| **Other Comprehensive Income, net of tax** |  |  |
| Net holding gains on securities available-for-sale | 10222 | 13860 |
| Total comprehensive income | $**97108** | $**83366** |
| **Net Income Per Common Share:** |  |  |
| Basic | $1.30 | $0.99 |
| Diluted | $1.29 | $0.98 |
| Cash dividends paid per common share | $0.38 | $0.34 |
| **Average Common Shares Outstanding:** |  |  |
| Basic | 67040473 | 70379835 |
| Diluted | 67387657 | 70679640 |

---

See accompanying Notes to Consolidated Financial Statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3

------

[**Table of Contents**](#toc)

**CATHAY GENERAL BANCORP AND SUBSIDIARIES**

**CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS**' **EQUITY** 

(Unaudited)

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  |  |  | ***Accumulated*** |  |  |  |
|  | ***Common Stock*** | ***Common Stock*** | ***Additional*** | ***Other*** |  |  | ***Total*** |
|  | ***Number of*** |  | ***Paid-in*** | ***Comprehensive*** | ***Retained*** | ***Treasury*** | ***Stockholders'*** |
| **Three Months Ended** | ***Shares*** | ***Amount*** | ***Capital*** | ***(Loss)/Income*** | ***Earnings*** | ***Stock*** | ***Equity*** |
|  | ($ In thousands, except share and per share data) | ($ In thousands, except share and per share data) | ($ In thousands, except share and per share data) | ($ In thousands, except share and per share data) | ($ In thousands, except share and per share data) | ($ In thousands, except share and per share data) | ($ In thousands, except share and per share data) |
| **Balance at December 31, 2025** | 67200126 | $918 | $1001401 | $(54400) | $2909677 | $(932208) | $2925388 |
| Dividend Reinvestment Plan | 14380 |  | 675 |  |  |  | 675 |
| Restricted stock units vested | 1032 |  |  |  |  |  |  |
| Shares withheld related to net share |  |  |  |  |  |  |  |
| settlement of RSUs | *—* |  | (38) |  |  |  | (38) |
| Purchases of treasury stock | (243499) |  |  |  |  | (12612) | (12612) |
| Stock-based compensation | *—* |  | 1571 |  |  |  | 1571 |
| Cash dividends of $0.38 per share | *—* |  |  |  | (25444) |  | (25444) |
| Other comprehensive income | *—* |  |  | 10222 |  |  | 10222 |
| Net income | *—* |  |  |  | 86886 |  | 86886 |
| **Balance at March 31, 2026** | **66972039** | $**918** | $**1003609** | $**(44178)** | $**2971119** | $**(944820)** | $**2986648** |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  |  |  |  | ***Accumulated*** |  |  |  |
|  | ***Common Stock*** | ***Common Stock*** | ***Additional*** | ***Other*** |  |  | ***Total*** |
|  | ***Number of*** |  | ***Paid-in*** | ***Comprehensive*** | ***Retained*** | ***Treasury*** | ***Stockholders'*** |
| **Three Months Ended** | ***Shares*** | ***Amount*** | ***Capital*** | ***(Loss)/Income*** | ***Earnings*** | ***Stock*** | ***Equity*** |
|  | ($ In thousands, except share and per share data) | ($ In thousands, except share and per share data) | ($ In thousands, except share and per share data) | ($ In thousands, except share and per share data) | ($ In thousands, except share and per share data) | ($ In thousands, except share and per share data) | ($ In thousands, except share and per share data) |
| **Balance at December 31, 2024** | **70863324** | $**916** | $**993962** | $**(85607)** | $**2688353** | $**(751920)** | $**2845704** |
| Dividend Reinvestment Plan | 15852 |  | 695 |  |  |  | 695 |
| Restricted stock units vested | 32438 |  |  |  |  |  |  |
| Stock issued to directors |  |  |  |  |  |  |  |
| Shares withheld related to net share |  |  |  |  |  |  |  |
| settlement of RSUs | *—* |  | (791) |  |  |  | (791) |
| Purchases of treasury stock | (876906) |  |  |  |  | (41465) | (41465) |
| Stock-based compensation | *—* |  | 1505 |  |  |  | 1505 |
| Cash dividends of $0.34 per share | *—* |  |  |  | (23855) |  | (23855) |
| Other comprehensive income | *—* |  |  | 13860 |  |  | 13860 |
| Net income | *—* |  |  |  | 69506 |  | 69506 |
| **Balance at March 31, 2025** | **70034708** | $**916** | $**995371** | $**(71747)** | $**2734004** | $**(793385)** | $**2865159** |

---

See accompanying Notes to Consolidated Financial Statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4

------

[**Table of Contents**](#toc)

**CATHAY GENERAL BANCORP AND SUBSIDIARIES** 

**CONSOLIDATED STATEMENTS OF CASH FLOWS**

(Unaudited)

---

| | | |
|:---|:---|:---|
|  | ***Three Months Ended March 31,*** | ***Three Months Ended March 31,*** |
|  | ***2026*** | ***2025*** |
|  | ($ In thousands) | ($ In thousands) |
| **Cash Flows from Operating Activities** |  |  |
| Net income | $86886 | $69506 |
| Adjustments to reconcile net income to net cash provided by operating activities: |  |  |
| Provision for credit losses | 18193 | 15500 |
| Deferred tax provision | 6662 | 978 |
| Depreciation and amortization | 1667 | 1835 |
| Amortization of right-of-use asset | 2377 | 2305 |
| Change in operating lease liabilities | 479 | 1269 |
| Net gains on sale and transfers of other real estate owned | (1277) |  |
| Net gains on sale of loans |  | (121) |
| Loss on sales or disposal of premises and equipment |  | 14 |
| Amortization on alternative energy partnerships, venture capital and other investments | 6740 | 9054 |
| Impairment loss on investment securities | 15685 |  |
| Amortization/accretion of securities available-for-sale premiums/discounts, net | (7340) | (5265) |
| Unrealized (gain)/ loss on equity securities | (17316) | 4191 |
| Stock-based compensation and stock issued to officers as compensation | 1571 | 1505 |
| Net change in accrued interest receivable and other assets | 11415 | 40065 |
| Net change in other liabilities | (27397) | (41877) |
| **Net cash provided by operating activities** | **98345** | **98959** |
| **Cash Flows from Investing Activities** |  |  |
| Purchase of securities available-for-sale | (515644) | (464837) |
| Proceeds from repayments, maturities and calls of securities available-for-sale | 501880 | 602868 |
| Proceeds from sale of other real estate owned | 2109 | 773 |
| &nbsp;&nbsp;&nbsp;&nbsp; Proceeds from sale of loans originally classified as held-for-investment |  | 15263 |
| Net increase in loans | (40359) | (6925) |
| Purchase of premises and equipment | (2319) | (2698) |
| Net (increase)/decrease in affordable housing investments and alternative energy partnerships | (6992) | 771 |
| **Net cash (used)/provided for investing activities** | **(61325)** | **145215** |
| **Cash Flows from Financing Activities** |  |  |
| (Decrease)/increase in deposits | (218527) | 131236 |
| Advances from Federal Home Loan Bank | 4331000 | 2399000 |
| Repayment of Federal Home Loan Bank borrowings | (4331000) | (2364000) |
| Cash dividends paid | (25444) | (23855) |
| Purchases of treasury stock | (12612) | (41465) |
| Proceeds from shares issued under Dividend Reinvestment Plan | 675 | 695 |
| Taxes paid related to net share settlement of RSUs | (38) | (791) |
| **Net cash (used)/provided for financing activities** | **(255946)** | **100820** |
| (Decrease)/increase in cash, cash equivalents, and restricted cash | (218926) | 344994 |
| Cash, cash equivalents, and restricted cash, beginning of the period | 1424409 | 1039520 |
| **Cash, cash equivalents, and restricted cash, end of the period** | $**1205483** | $**1384514** |
| **Supplemental Cash Flow Information** |  |  |
| Cash paid during the period: |  |  |
| Interest | $131460 | $147629 |
| Income taxes | $4393 | $370 |
| Non-cash investing and financing activities: |  |  |
| Net change in unrealized holding gain on securities available-for-sale, net of tax | $10222 | $13860 |
| Loans transferred from held-for-investment to held-for-sale | $6902 | $26901 |
| Transfers to other real estate owned from loans held-for-investment | $3932 | $1186 |

---

See accompanying Notes to Consolidated Financial Statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5

------

[**Table of Contents**](#toc)

**CATHAY GENERAL BANCORP AND SUBSIDIARIES**

**NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)**

***<u>*1.* Business</u>***

Cathay General Bancorp ("Bancorp") is the holding company for Cathay Bank (the "Bank" and, together, with Bancorp, the "Company"), and twelve limited partnerships investing in affordable housing investments in which the Bank is the sole limited partner. Bancorp also owns 100% of the common stock of *five* statutory business trusts created for the purpose of issuing capital securities. The Bank was founded in *1962* and offers a wide range of financial services. As of *March 31, 2026*, the Bank operates 24 branches in Southern California, 17 branches in Northern California, 9 branches in New York State, four in Washington State, two in Illinois, two in Texas, one in Maryland, Massachusetts, Nevada, and New Jersey, one in Hong Kong, and a representative office in Taipei, Beijing, and Shanghai. Deposit accounts at the Hong Kong branch are *not* insured by the Federal Deposit Insurance Corporation (the "FDIC"). Current activities of Beijing, Shanghai, and Taipei representative offices are limited to coordinating the transportation of documents to Bank's head office and performing liaison services.

***<u>*2.* Basis of Presentation and Summary of Significant Accounting Policies</u>***

The accompanying unaudited Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") for interim financial information and with the instructions to Form *10*-Q and Article *10* of Regulation S-*X.* Accordingly, they do *not* include all the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the interim periods presented are *not* necessarily indicative of the results that *may* be expected for the year ending *March 31, 2026*. For further information, refer to the audited Consolidated Financial Statements and Notes included in the Company's Annual Report on Form *10*-K for the year ended *December 31, 2025*, filed with the SEC on *March 2, 2026* (the *"2025* Form *10*-K").

The preparation of the Consolidated Financial Statements in accordance with GAAP requires management of the Company to make estimates and judgments that affect the reported amounts of assets and liabilities, revenues and expenses, and related disclosures of contingent assets and liabilities at the date of the Consolidated Financial Statements. Actual results could differ from those estimates. The Company expects that the most significant estimate subject to change is the allowance for loan losses.

Certain prior period amounts disclosed have been reclassified to conform to the current presentation with *no* impact on previously reported net income or stockholders' equity.

***<u>*3.* Recently Issued Accounting Standards Pending Adoption</u>***

In *December 2025,* ASU *2025-11,* "Interim Reporting (Topic *270*): Narrow-Scope Improvements", was issued. ASU *2025*-*11* clarifies and enhances guidance under ASC *270* on interim financial reporting by (i) clarifying the scope of ASC *270* such that it now explicitly applies only to entities that issue complete interim financial statements and related notes under U.S. GAAP, (ii) establishing clear guidance on the form of interim statements and notes, incorporating a comprehensive list of required interim disclosures drawn from across the ASC, and (iii) introducing a requirement to disclose material events and changes occurring after the end of the last annual period that could impact interim results. ASU *2025*-*11* will be effective for us for interim periods beginning in *2028,* though early adoption is permitted. ASU *2025*-*11* is *not* expected to have a significant impact on our financial statements.

In *November 2025,* ASU *2025-09,* "Derivatives and Hedging (Topic *815*): Hedge Accounting Improvements", was issued. ASU *2025*-*09* amends ASC *815* to align hedge accounting more closely with an entity's economic risk management practices. Key amendments include (i) to allow designating a variable price component of a nonfinancial forecasted purchase or sale as the hedged risk, (ii) to allow grouping individual forecasted transactions with similar (*not* identical) risk exposures, (iii) a new model for hedging forecasted interest on variable-rate debt, enabling changes in index or tenor without de-designation, subject to simplifying assumptions, and (iv) additional clarifications related to hedge accounting of nonfinancial components, net written options, and dual-hedge strategies. ASU *2025*-*09* will be effective for us beginning in *2027,* though early adoption is permitted. ASU *2025*-*09* is *not* expected to have a significant impact on our financial statements.

In *November 2025,* ASU *2025-08,* "Financial Instruments - Credit Losses (Topic *326*): Purchased Loans", was issued. ASU *2025*-*08* expands the scope of the "gross-up" method, formerly applicable only to purchased credit-deteriorated ("PCD") assets, to include acquired non-PCD loans that meet certain criteria, now referred to as "purchased seasoned loans" (PSLs). Under this model, an allowance for expected credit losses is recognized at acquisition, offsetting the loan's amortized cost basis, thereby eliminating the day-*one* credit-loss expense previously required for non-PCD assets. PSLs are defined as non-PCD loans acquired either (i) through a business combination, or (ii) purchased more than *90* days after origination when the acquirer was *not* involved in origination. ASU *2025*-*08* will be effective for us, on a prospective basis for loans acquired on or after the adoption date, for interim and annual reporting periods beginning in *2027,* though early adoption is permitted. ASU *2025*-*08* is *not* expected to have a significant impact on our financial statements.

In *September 2025,* ASU *No. 2025*-*06,* "Intangibles - Goodwill and Other - Internal-Use Software (Subtopic *350*-*40*): Targeted Improvements to the Accounting for Internal-Use Software", was issued. ASU *2025*-*06* simplifies and modernizes the accounting for internal-use software by removing prescriptive project stage guidance and introducing a new capitalization threshold. Under the revised standard, software development costs are capitalized when management authorizes and commits funding for the project, and it is probable the software will be completed and used as intended. ASU *2025*-*06* will be effective in *2028.* ASU *2025*-*06* is *not* expected to have a significant impact on our financial statements.

In *November 2024,* ASU *No. 2024*-*03,* "Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic *220*-*40*): Disaggregation of Income Statement Expenses", was issued. This ASU requires disaggregated disclosure of income statement expenses for public business entities. ASU *2024*-*03* requires new financial statement disclosures in tabular format, disaggregating information about prescribed categories underlying any relevant income statement expense caption. The prescribed categories include, among other things, employee compensation, depreciation, and intangible asset amortization. Additionally, entities must disclose the total amount of selling expenses and, in annual reporting periods, an entity's definition of selling expenses. ASU *2024*-*03* is effective for us, on a prospective basis, for annual periods beginning in *2027,* and interim periods within fiscal years beginning in *2028,* though early adoption and retrospective application is permitted. ASU *2024*-*03* is *not* expected to have a significant impact on our financial statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *6*

------

[**Table of Contents**](#toc)

***<u>*4.* Cash, Cash Equivalents and Restricted Cash</u>***

The Company manages its cash and cash equivalents based upon the Company's operating, investment, and financing activities. Cash and cash equivalents, for the purposes of reporting cash flows, consist of cash and due from banks, short-term investments, and interest-bearing deposits. Cash and due from banks include cash on hand, cash items in transit, cash due from the Federal Reserve Bank of San Francisco ("FRBSF") and other financial institutions. Short-term investments and interest-bearing deposits include cash placed with other banks with original maturity of *three* months or less.

The Company had average excess balance with FRBSF of $1.11 billion as of *March 31, 2026*, and $1.14 billion as of *December 31, 2025*. As of *March 31, 2026*, and *December 31, 2025*, the Company had $15.1 million and $12.1 million, respectively, as cash margin that serves as collateral on deposits in a cash margin account for interest rate swaps. Of the balances held in the cash margin account $3.2 million and $4.3 million are restricted as of *March 31, 2026*, and *December 31, 2025*, respectively.

***<u>*5.* Investment Securities</u>***

The following tables set forth the amortized cost, gross unrealized gains, gross unrealized losses, and fair value of securities available-for-sale ("AFS") as of *March 31, 2026*, and *December 31, 2025*

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | ***March 31, 2026*** | ***March 31, 2026*** | ***March 31, 2026*** | ***March 31, 2026*** |
|  |  | ***Gross*** | ***Gross*** |  |
|  | ***Amortized*** | ***Unrealized*** | ***Unrealized*** |  |
|  | ***Cost*** | ***Gains*** | ***Losses*** | ***Fair Value*** |
|  | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) |
| **Securities AFS** |  |  |  |  |
| U.S. treasury securities | $916093 | $12 | $155 | $915950 |
| U.S. government agency entities | 5079 | 50 | 109 | 5020 |
| Mortgage-backed securities | 668164 | 323 | 60649 | 607838 |
| Collateralized mortgage obligations | 23540 |  | 1554 | 21986 |
| Corporate debt securities | 127982 | 60 | 696 | 127346 |
| **Total** | $**1740858** | $**445** | $**63163** | $**1678140** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | ***December 31, 2025*** | ***December 31, 2025*** | ***December 31, 2025*** | ***December 31, 2025*** |
|  |  | ***Gross*** | ***Gross*** |  |
|  | ***Amortized*** | ***Unrealized*** | ***Unrealized*** |  |
|  | ***Cost*** | ***Gains*** | ***Losses*** | ***Fair Value*** |
|  | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) |
| **Securities AFS** |  |  |  |  |
| U.S. treasury securities | $827763 | $430 | $— | $828193 |
| U.S. government agency entities | 5888 | 52 | 118 | 5822 |
| U.S. government sponsored entities | 25000 | 11 |  | 25011 |
| Mortgage-backed securities | 704213 | 548 | 75324 | 629437 |
| Collateralized mortgage obligations | 24454 |  | 1706 | 22748 |
| Corporate debt securities | 148133 | 101 | 1222 | 147012 |
| **Total** | $**1735451** | $**1142** | $**78370** | $**1658223** |

---

AFS securities having a carrying value of $22.5 million and $22.8 million as of *March 31, 2026,* and *December 31, 2025,* respectively, were pledged to secure public deposits and other borrowings.

As of *March 31, 2026*, and *December 31, 2025*, the amortized cost of AFS securities excluded accrued interest receivables of $2.4 million and $3.0 million, respectively, which are included in accrued interest receivable on the Consolidated Balance Sheets. For the Company's accounting policy related to AFS securities accrued interest receivable, *see Note *1* - Summary of Significant Accounting Policies* – *Securities Available for Sale* – *Allowance for Credit Losses on Available for Sale Securities* to the Consolidated Financial Statements in the Company's *2025* Form *10*-K.

The amortized cost and fair value of AFS securities as of *March 31, 2026*, by contractual maturities, are set forth in the table below. Actual maturities *may* differ from contractual maturities because borrowers *may* have the right to call or repay obligations with or without call or repayment penalties.

---

| | | |
|:---|:---|:---|
|  | ***March 31, 2026*** | ***March 31, 2026*** |
|  | ***Securities AFS*** | ***Securities AFS*** |
|  | ***Amortized Cost*** | ***Fair Value*** |
|  | ($ In thousands) | ($ In thousands) |
| Due in one year or less | $1011140 | $1010268 |
| Due after one year through five years | 64163 | 64161 |
| Due after five years through ten years | 54265 | 54067 |
| Due after ten years | 611290 | 549644 |
| **Total** | $**1740858** | $**1678140** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *7*

------

[**Table of Contents**](#toc)

The following tables set forth the gross unrealized losses and related fair value of the Company's investment portfolio, aggregated by investment category and the length of time that individual security has been in a continuous unrealized loss position, as of *March 31, 2026*, and *December 31, 2025*:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | ***March 31, 2026*** | ***March 31, 2026*** | ***March 31, 2026*** | ***March 31, 2026*** | ***March 31, 2026*** | ***March 31, 2026*** |
|  | ***Less than 12 Months*** | ***Less than 12 Months*** | ***12 Months or Longer*** | ***12 Months or Longer*** | ***Total*** | ***Total*** |
|  |  | ***Gross*** |  | ***Gross*** |  | ***Gross*** |
|  | ***Fair*** | ***Unrealized*** | ***Fair*** | ***Unrealized*** | ***Fair*** | ***Unrealized*** |
|  | ***Value*** | ***Losses*** | ***Value*** | ***Losses*** | ***Value*** | ***Losses*** |
|  | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) |
| **Securities AFS** |  |  |  |  |  |  |
| U.S. treasury securities | $616825 | $155 | $— | $— | $616825 | $155 |
| U.S. government agency entities | 3653 |  | 1300 | 109 | 4953 | 109 |
| Mortgage-backed securities | 209464 | 451 | 384728 | 60198 | 594192 | 60649 |
| Collateralized mortgage obligations | 8598 |  | 13388 | 1554 | 21986 | 1554 |
| Corporate debt securities | 2982 |  | 74304 | 696 | 77286 | 696 |
| **Total** | $**841522** | $**606** | $**473720** | $**62557** | $**1315242** | $**63163** |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | ***December 31, 2025*** | ***December 31, 2025*** | ***December 31, 2025*** | ***December 31, 2025*** | ***December 31, 2025*** | ***December 31, 2025*** |
|  | ***Less than 12 Months*** | ***Less than 12 Months*** | ***12 Months or Longer*** | ***12 Months or Longer*** | ***Total*** | ***Total*** |
|  |  | ***Gross*** |  | ***Gross*** |  | ***Gross*** |
|  | ***Fair*** | ***Unrealized*** | ***Fair*** | ***Unrealized*** | ***Fair*** | ***Unrealized*** |
|  | ***Value*** | ***Losses*** | ***Value*** | ***Losses*** | ***Value*** | ***Losses*** |
|  | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) |
| **Securities AFS** |  |  |  |  |  |  |
| U.S. government agency entities | $834 | $1 | $3585 | $117 | $4419 | $118 |
| Mortgage-backed securities | 207 |  | 600658 | 75324 | 600865 | 75324 |
| Collateralized mortgage obligations |  |  | 22747 | 1706 | 22747 | 1706 |
| Corporate debt securities |  |  | 76912 | 1222 | 76912 | 1222 |
| **Total** | $**1041** | $**1** | $**703902** | $**78369** | $**704943** | $**78370** |

---

As of *March 31, 2026*, the Company had a total of 100 AFS securities in a gross unrealized loss position with *no* credit impairment, consisting primarily of 73 mortgage-backed securities, 12 U.S. treasury securities, seven corporate debt securities, six U.S. government agency securities, and two collateralized mortgage obligations. In comparison, as of *December 31, 2025*, the Company has a total of 159 AFS securities in a gross unrealized loss position with *no* credit impairment, consisting primarily of 138 mortgage-backed securities, ten U.S. government agency securities, eight corporate debt securities, and three collateralized mortgage obligations.

The AFS securities that were in an unrealized loss position at *March 31, 2026,* were evaluated to determine whether the decline in fair value below the amortized cost basis resulted from a credit loss or other factors. For a discussion of the factors and criteria the Company uses in analyzing securities for impairment related to credit losses, *see Note *1* - Summary of Significant Accounting Policies - Allowance for Credit Losses on Available for Sale Securities* to the Consolidated Financial Statements in the Company's *2025* Form *10*-K.

During the quarter ended *March 31, 2026,* the Company recognized an impairment loss of $15.7 million on certain available-for-sale investment securities in connection with the Company's decision to sell those securities. In *April 2026,* the Company sold these securities, which had a book value of $210.5 million, resulting in a realized loss of $15.7 million.

The unrealized losses on the remaining AFS securities were primarily attributable to changes in the yield curve and wider liquidity and credit spreads. The issuers have *not,* to the Company's knowledge, exhibited any conditions that would indicate a risk of default. Other than the securities identified for sale, the Company expects to recover the amortized cost basis of its AFS securities and has *no* intent to sell, nor is it more likely than *not* that it will be required to sell, securities in an unrealized loss position before recovery. Accordingly, no allowance for credit losses was recorded on AFS securities as of *March 31, 2026,* and no provision for credit losses was recognized for the quarter.

***<u>*6.* Loans</u>*** 

Most of the Company's business activities are with clients located in the high-density Asian-populated areas of Southern and Northern California; New York City, New York; Dallas and Houston, Texas; Seattle, Washington; Boston, Massachusetts; Chicago, Illinois; Edison, New Jersey; Rockville, Maryland; and Las Vegas, Nevada. The Company also has loan clients in Hong Kong. The Company has *no* significant industry concentration, and generally its loans, when secured, are secured by real property or other collateral of the borrowers. The Company generally expects loans to be paid off from the operating profits of the borrowers, from refinancing by other lenders, or through sale by the borrowers of the secured collateral.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *8*

------

[**Table of Contents**](#toc)

The types of loans in the Company's Consolidated Balance Sheets as of *March 31, 2026*, and *December 31, 2025*, were as follows:

---

| | | |
|:---|:---|:---|
|  | ***March 31, 2026*** | ***December 31, 2025*** |
|  | ($ In thousands) | ($ In thousands) |
| Commercial loans | $3282557 | $3184556 |
| Construction loans | 289042 | 337550 |
| Commercial real estate loans | 10588726 | 10564744 |
| Residential mortgage loans | 5778531 | 5832094 |
| Equity lines | 233140 | 226444 |
| Installment and other loans | 2593 | 1814 |
| Gross loans | $20174589 | $20147202 |
| Allowance for loan losses | (208786) | (195911) |
| Unamortized deferred loan fees, net | (14164) | (14903) |
| **Total loans held for investment, net** | $**19951639** | $**19936388** |

---

As of *March 31, 2026*, and *December 31, 2025*, recorded investment in non-accrual loans was $89.0 million and $112.4 million, respectively. For non-accrual loans, the amounts previously charged-off represent 7.7% and 14.4% of the contractual balances for non-accrual loans as of *March 31, 2026*, and *December 31, 2025*, respectively.

At *March 31, 2026,* the Bank pledged $1.38 billion of its commercial loans to the Federal Reserve Bank's Discount Window under the Borrower-in-Custody program. The Bank had borrowing capacity of $1.26 billion from the Federal Reserve Bank Discount Window at *March 31, 2026.*

The following table presents non-accrual loans and the related allowance as of *March 31, 2026*, and *December 31, 2025*.

---

| | | | |
|:---|:---|:---|:---|
|  | ***March 31, 2026*** | ***March 31, 2026*** | ***March 31, 2026*** |
|  | ***Unpaid Principal Balance*** | ***Recorded Investment*** | ***Allowance*** |
|  | ($ In thousands) | ($ In thousands) | ($ In thousands) |
| **With no allocated allowance:** |  |  |  |
| Commercial loans | $4851 | $4781 | $*—* |
| Commercial real estate loans | 39543 | 31700 | *—* |
| Residential mortgage loans and equity lines | 18223 | 17652 | *—* |
| Subtotal | $62617 | $54133 | $*—* |
| **With allocated allowance:** |  |  |  |
| Commercial loans | $5608 | $2884 | $761 |
| Commercial real estate loans | 24247 | 19391 | 8937 |
| Residential mortgage loans and equity lines | 13478 | 12596 | 45 |
| Subtotal | $43333 | $34871 | $9743 |
| **Total non-accrual loans** | $**105950** | $**89004** | $**9743** |

---

---

| | | | |
|:---|:---|:---|:---|
|  | ***December 31, 2025*** | ***December 31, 2025*** | ***December 31, 2025*** |
|  | ***Unpaid Principal Balance*** | ***Recorded Investment*** | ***Allowance*** |
|  | ($ In thousands) | ($ In thousands) | ($ In thousands) |
| **With no allocated allowance:** |  |  |  |
| Commercial loans | $25154 | $14899 | $*—* |
| Commercial real estate loans | 58213 | 39874 | *—* |
| Residential mortgage loans and equity lines | 32854 | 31354 | *—* |
| Subtotal | $116221 | $86127 | $*—* |
| **With allocated allowance:** |  |  |  |
| Commercial loans | $6887 | $6599 | $3409 |
| Commercial real estate loans | 24438 | 19637 | 8932 |
| Subtotal | $31325 | $26236 | $12341 |
| **Total non-accrual loans** | $**147546** | $**112363** | $**12341** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *9*

------

[**Table of Contents**](#toc)

The following tables present the average recorded investment and interest income recognized on non-accrual loans for the period indicated:

---

| | | |
|:---|:---|:---|
|  | ***Three Months Ended*** | ***Three Months Ended*** |
|  | ***March 31, 2026*** | ***March 31, 2026*** |
|  | ***Average Recorded Investment*** | ***Interest Income Recognized*** |
|  | ($ In thousands) | ($ In thousands) |
| Commercial loans | $13397 | $2 |
| Commercial real estate loans | 54790 |  |
| Residential mortgage loans and equity lines | 32139 |  |
| **Total non-accrual loans** | $**100326** | $**2** |

---

---

| | | |
|:---|:---|:---|
|  | ***Three Months Ended*** | ***Three Months Ended*** |
|  | ***March 31, 2025*** | ***March 31, 2025*** |
|  | ***Average Recorded Investment*** | ***Interest Income Recognized*** |
|  | ($ In thousands) | ($ In thousands) |
| Commercial loans | $56112 | $4 |
| Commercial real estate loans | 83678 |  |
| Residential mortgage loans and equity lines | 28651 |  |
| **Total non-accrual loans** | $**168441** | $**4** |

---

The following tables present the aging of the loan portfolio by type as of *March 31, 2026*, and as of *December 31, 2025*:

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | ***March 31, 2026*** | ***March 31, 2026*** | ***March 31, 2026*** | ***March 31, 2026*** | ***March 31, 2026*** | ***March 31, 2026*** | ***March 31, 2026*** |
|  | ***Accruing*** | ***Accruing*** | ***Accruing*** |  |  |  |  |
|  | ***30-59 Days Past Due*** | ***60-89 Days Past Due*** | ***90 Days or More Past Due*** | ***Non-accrual Loans*** | ***Total Past Due*** | ***Loans Not Past Due*** | ***Total*** |
|  | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) |
| **Type of Loans:** |  |  |  |  |  |  |  |
| Commercial loans | $36551 | $3330 | $5491 | $7665 | $53037 | $3229520 | $3282557 |
| Construction loans |  |  |  |  |  | 289042 | 289042 |
| Commercial real estate loans | 48357 | 10419 |  | 51091 | 109867 | 10478859 | 10588726 |
| Residential mortgage loans and equity lines | 44921 | 1536 |  | 30248 | 76705 | 5934966 | 6011671 |
| Installment and other loans |  |  |  |  |  | 2593 | 2593 |
| **Total loans** | $**129829** | $**15285** | $**5491** | $**89004** | $**239609** | $**19934980** | $**20174589** |

---

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
|  | ***December 31, 2025*** | ***December 31, 2025*** | ***December 31, 2025*** | ***December 31, 2025*** | ***December 31, 2025*** | ***December 31, 2025*** | ***December 31, 2025*** |
|  | ***Accruing*** | ***Accruing*** | ***Accruing*** |  |  |  |  |
|  | ***30-59 Days Past Due*** | ***60-89 Days Past Due*** | ***90 Days or More Past Due*** | ***Non-accrual Loans*** | ***Total Past Due*** | ***Loans Not Past Due*** | ***Total*** |
|  | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) |
| **Type of Loans:** |  |  |  |  |  |  |  |
| Commercial loans | $13561 | $1376 | $— | $21498 | $36435 | $3148121 | $3184556 |
| Construction loans |  |  |  |  |  | 337550 | 337550 |
| Commercial real estate loans | 5062 | 6254 | 1000 | 59511 | 71827 | 10492917 | 10564744 |
| Residential mortgage loans and equity lines | 31440 | 10861 |  | 31354 | 73655 | 5984883 | 6058538 |
| Installment and other loans |  |  |  |  |  | 1814 | 1814 |
| **Total loans** | $**50063** | $**18491** | $**1000** | $**112363** | $**181917** | $**19965285** | $**20147202** |

---

The Company evaluates loan modifications made to borrowers experiencing financial difficulty to determine whether the modification results in a new loan under ASC *310-20.* For modifications that do *not* result in a new loan, the Company uses the post-modification contractual terms, including the post-modification contractual interest rate, when applying a discounted cash flow method to estimate expected credit losses. Loan modifications made to borrowers experiencing financial difficulty are individually evaluated. The modification *may* include, but is *not* limited to, term extensions, payment delays, interest rate reductions, or a combination of such modifications.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *10*

------

[**Table of Contents**](#toc)

The following table presents the amortized cost of loans modified to borrowers experiencing financial difficulty disaggregated by class of financing receivable, type of concession granted and the financial effects of the modifications for the *three* months ended *March 31, 2026*, and *March 31, 2025*, by loan class and modification type. The tables do *not* include those modifications that only resulted in an insignificant payment delay.

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | ***Three Months Ended March 31, 2026*** | ***Three Months Ended March 31, 2026*** | ***Three Months Ended March 31, 2026*** | ***Three Months Ended March 31, 2026*** |  | ***Financial Effects of Loan Modifications*** | ***Financial Effects of Loan Modifications*** | ***Financial Effects of Loan Modifications*** |
|  | ***Term Extension*** | ***Payment Delay*** | ***Combo-Rate Reduction/Term Extension/Payment Delay*** | ***Total*** | ***Modification as a % of Loan Class*** | ***Weighted-Average Reduction in Rate*** | ***Weighted-Average Term Extension (in Years)*** | ***Weighted-Average Payment Deferral (in Years)*** |
|  | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) |  |  |  |  |
| **Loan Type** |  |  |  |  |  |  |  |  |
| Commercial loans | $10332 | $— | $8700 | $19032 | 0.58% | 0.00 | 0.8 | 0.1 |
| Commercial real estate loans | 26203 |  | 2449 | 28652 | 0.27% | 1.01 | 1 | 0 |
| Construction loans | 10698 |  | 25950 | 36648 | 12.68% | 0.08 | 0.6 | 0 |
| **Total** | $**47233** | $**—** | $**37099** | $**84332** |  |  |  |  |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | ***Three Months Ended March 31, 2025*** | ***Three Months Ended March 31, 2025*** | ***Three Months Ended March 31, 2025*** | ***Three Months Ended March 31, 2025*** |  | ***Financial Effects of Loan Modifications*** | ***Financial Effects of Loan Modifications*** | ***Financial Effects of Loan Modifications*** |
|  | ***Term Extension*** | ***Payment Delay*** | ***Combo-Rate Reduction/Term Extension/Payment Delay*** | ***Total*** | ***Modification as a % of Loan Class*** | ***Weighted-Average Reduction in Rate*** | ***Weighted-Average Term Extension (in Years)*** | ***Weighted-Average Payment Deferral (in Years)*** |
|  | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) |  |  |  |  |
| **Loan Type** |  |  |  |  |  |  |  |  |
| Commercial loans | $5431 | $130 | $974 | $6535 | 0.22% | 0.92 | 1.9 | 0.1 |
| Commercial real estate loans |  |  | 3201 | 3201 | 0.03% | 0.86 | 1.7 | 1.7 |
| Residential mortgage loans |  | 217 |  | 217 | 0.00% | 0.00 | 0.0 | 2.0 |
| **Total** | $**5431** | $**347** | $**4175** | $**9953** |  |  |  |  |

---

The Company considers a loan to be in payment default once it is *90* days contractually past due under the modified terms. The Company closely monitors the performance of modified loans to borrowers experiencing financial difficulty to understand the effectiveness of its modification efforts.

The following table presents information on loans that defaulted during the *three* months ended *March 31, 2026*, that received modifications within the *twelve* months preceding payment default. There were no loans that received modifications within the *twelve* months preceding payment default that subsequently defaulted during the *three* months ended *March 31, 2025*.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** | **Three Months Ended March 31, 2026** |
|  | **Term Extension** | **Payment Delay** | **Combo-Rate Reduction/Term Extension/Payment Delay** | **Total** |
|  | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) |
| **Loan Type** |  |  |  |  |
| Commercial loans | $2430 | $— | $— | $2430 |
| **Total** | $**2430** | $**—** | $**—** | $**2430** |

---

The following table presents the performance of loans that were modified in the *twelve* months ended *March 31, 2026*, and *2025*.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | ***As of March 31, 2026*** | ***As of March 31, 2026*** | ***As of March 31, 2026*** | ***As of March 31, 2026*** |
|  | ***Current*** | ***30–89 Days Past Due*** | ***90+ Days Past Due*** | ***Total*** |
|  | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) |
| **Loan Type** |  |  |  |  |
| Commercial loans | $2700 | $16332 | $— | $19032 |
| Commercial real estate loans | 28652 |  |  | 28652 |
| Construction loans | 36648 |  |  | 36648 |
| **Total** | $**68000** | $**16332** | $**—** | $**84332** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | ***As of March 31, 2025*** | ***As of March 31, 2025*** | ***As of March 31, 2025*** | ***As of March 31, 2025*** |
|  | ***Current*** | ***30–89 Days Past Due*** | ***90+ Days Past Due*** | ***Total*** |
|  | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) |
| **Loan Type** |  |  |  |  |
| Commercial loans | $4795 | $— | $1740 | $6535 |
| Commercial real estate loans | 3201 |  |  | 3201 |
| Residential mortgage loans | 217 |  |  | 217 |
| **Total** | $**8213** | $**—** | $**1740** | $**9953** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *11*

------

[**Table of Contents**](#toc)

Under the Company's internal underwriting policy, an evaluation is performed of the probability that the borrower will be in payment default on any of its debt in the foreseeable future without the modification in order to determine whether a borrower is experiencing financial difficulty.

As of *March 31, 2026*, there were no commitments to lend additional funds to borrowers experiencing financial difficulty and whose loans were modified.

As part of the on-going monitoring of the credit quality of our loan portfolio, the Company utilizes a risk grading matrix to assign a risk grade to each loan. Loans are risk rated based on analysis of the current state of the borrower's credit quality. The analysis of credit quality includes a review of sources of repayment, the borrower's current financial and liquidity status and other relevant information. The risk rating categories can be generally described by the following grouping for non-homogeneous loans:

**●** **Pass/Watch** – These loans range from minimal credit risk to higher than average, but still acceptable, credit risk. The loans have sufficient sources of repayment to repay the loans in full, in accordance with all the terms and conditions and remain currently well protected by collateral values.

**●** **Special Mention** – Borrower is fundamentally sound, and loan is currently protected but adverse trends are apparent that, if *not* corrected, *may* affect ability to repay. Primary source of loan repayment remains viable but there is increasing reliance on collateral or guarantor support.

**●** **Substandard** – These loans are inadequately protected by current sound net worth, paying capacity, or collateral. Well-defined weaknesses exist that could jeopardize repayment of debt. Loss *may not* be imminent, but if weaknesses are *not* corrected, there is a good possibility of some loss.

**●** **Doubtful** – The possibility of loss is extremely high, but due to identifiable and important pending events (which *may* strengthen the loan), a loss classification is deferred until the situation is better defined.

**●** **Loss** – These loans are considered uncollectible and of such little value that to continue to carry the loan as an active asset is *no* longer warranted.

The following table summarizes the Company's loans held for investment and current year-to-date gross write-offs as of *March 31, 2026*, and *December 31, 2025*, presented by loan portfolio segments, internal risk ratings and vintage year. The vintage year is the year of origination, renewal or major modification. Revolving Loans that are converted to term loans presented in the table below are excluded from the term loans by vintage year columns.

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | ***Loans Amortized Cost Basis by Origination Year*** | ***Loans Amortized Cost Basis by Origination Year*** | ***Loans Amortized Cost Basis by Origination Year*** | ***Loans Amortized Cost Basis by Origination Year*** | ***Loans Amortized Cost Basis by Origination Year*** | ***Loans Amortized Cost Basis by Origination Year*** |  |  |  |
| **March 31, 2026** | ***2026*** | ***2025*** | ***2024*** | ***2023*** | ***2022*** | ***Prior*** | ***Revolving Loans*** | ***Revolving Converted to Term Loans*** | ***Total*** |
|  | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) |
| **Commercial loans** |  |  |  |  |  |  |  |  |  |
| Pass/Watch | $131671 | $434946 | $151294 | $205697 | $153627 | $219863 | $1753385 | $7002 | $3057485 |
| Special Mention |  |  | 29417 | 325 | 1320 | 3851 | 56262 |  | 91175 |
| Substandard |  | 14641 | 1367 | 14633 | 1940 | 11732 | 82913 | 951 | 128177 |
| Doubtful |  |  |  |  | 1476 |  |  |  | 1476 |
| **Total** | $**131671** | $**449587** | $**182078** | $**220655** | $**158363** | $**235446** | $**1892560** | $**7953** | $**3278313** |
| YTD gross write-offs | $— | $19 | $2204 | $— | $550 | $2790 | $2408 | $— | $7971 |
| **Construction loans** |  |  |  |  |  |  |  |  |  |
| Pass/Watch | $3216 | $81039 | $75035 | $30470 | $19727 | $30592 | $1517 | $— | $241596 |
| Special Mention |  |  |  | 2816 |  |  |  |  | 2816 |
| Substandard |  |  |  | 11282 |  | 32086 |  |  | 43368 |
| **Total** | $**3216** | $**81039** | $**75035** | $**44568** | $**19727** | $**62678** | $**1517** | $**—** | $**287780** |
| YTD gross write-offs | $— | $— | $— | $— | $— | $— | $— | $— | $— |
| **Commercial real estate loans** |  |  |  |  |  |  |  |  |  |
| Pass/Watch | $483777 | $1924785 | $1278679 | $1542047 | $1402915 | $3142672 | $210752 | $— | $9985627 |
| Special Mention | 25404 | 8543 | 57762 | 134337 | 67865 | 52988 | 22694 |  | 369593 |
| Substandard | 2449 |  | 21373 | 22674 | 26424 | 132171 | 1193 | 1088 | 207372 |
| Doubtful |  |  |  |  |  | 17843 |  |  | 17843 |
| **Total** | $**511630** | $**1933328** | $**1357814** | $**1699058** | $**1497204** | $**3345674** | $**234639** | $**1088** | $**10580435** |
| YTD gross write-offs | $— | $— | $— | $— | $— | $1368 | $— | $— | $1368 |
| **Residential mortgage loans** |  |  |  |  |  |  |  |  |  |
| Pass/Watch | $184849 | $946878 | $453001 | $860780 | $878357 | $2414419 | $— | $— | $5738284 |
| Special Mention |  |  |  | 560 | 2811 | 6295 |  |  | 9666 |
| Substandard |  | 44 | 2235 | 4913 | 3764 | 18696 |  |  | 29652 |
| **Total** | $**184849** | $**946922** | $**455236** | $**866253** | $**884932** | $**2439410** | $**—** | $**—** | $**5777602** |
| YTD gross write-offs | $— | $— | $— | $17 | $— | $— | $— | $— | $17 |
| **Equity lines** |  |  |  |  |  |  |  |  |  |
| Pass/Watch | $— | $— | $— | $— | $— | $— | $215933 | $15404 | $231337 |
| Substandard |  |  |  |  |  |  | 1946 | 418 | 2364 |
| **Total** | $**—** | $**—** | $**—** | $**—** | $**—** | $**—** | $**217879** | $**15822** | $**233701** |
| YTD gross write-offs | $— | $— | $— | $— | $— | $— | $— | $— | $— |
| **Installment and other loans** |  |  |  |  |  |  |  |  |  |
| Pass/Watch | $1819 | $693 | $— | $— | $82 | $— | $— | $— | $2594 |
| **Total** | $**1819** | $**693** | $**—** | $**—** | $**82** | $**—** | $**—** | $**—** | $**2594** |
| YTD gross write-offs | $— | $— | $— | $— | $— | $— | $— | $— | $— |
| **Total loans** | $**833185** | $**3411569** | $**2070163** | $**2830534** | $**2560308** | $**6083208** | $**2346595** | $**24863** | $**20160425** |
| **Total YTD gross write-offs** | $**—** | $**19** | $**2204** | $**17** | $**550** | $**4158** | $**2408** | $**—** | $**9356** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *12*

------

[**Table of Contents**](#toc)

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | ***Loans Amortized Cost Basis by Origination Year*** | ***Loans Amortized Cost Basis by Origination Year*** | ***Loans Amortized Cost Basis by Origination Year*** | ***Loans Amortized Cost Basis by Origination Year*** | ***Loans Amortized Cost Basis by Origination Year*** | ***Loans Amortized Cost Basis by Origination Year*** |  |  |  |
| **December 31, 2025** | ***2025*** | ***2024*** | ***2023*** | ***2022*** | ***2021*** | ***Prior*** | ***Revolving Loans*** | ***Revolving Converted to Term Loans*** | ***Total*** |
|  | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) |
| **Commercial loans** |  |  |  |  |  |  |  |  |  |
| Pass/Watch | $384065 | $190685 | $220174 | $154865 | $157979 | $85858 | $1702322 | $6269 | $2902217 |
| Special Mention |  | 33459 |  | 1462 | 5000 | 3875 | 117738 |  | 161534 |
| Substandard | 16414 | 2166 | 16962 | 2479 | 2615 | 10443 | 61790 | 1031 | 113900 |
| Doubtful |  |  |  | 1805 |  | 297 |  |  | 2102 |
| **Total** | $**400479** | $**226310** | $**237136** | $**160611** | $**165594** | $**100473** | $**1881850** | $**7300** | $**3179753** |
| YTD gross write-offs | $— | $175 | $715 | $2752 | $4469 | $12503 | $12487 | $— | $33101 |
| **Construction loans** |  |  |  |  |  |  |  |  |  |
| Pass/Watch | $86893 | $69113 | $37801 | $68635 | $30283 | $— | $1298 | $— | $294023 |
| Special Mention |  |  | 9235 |  |  |  |  |  | 9235 |
| Substandard |  |  |  |  | 26060 | 6636 |  |  | 32696 |
| **Total** | $**86893** | $**69113** | $**47036** | $**68635** | $**56343** | $**6636** | $**1298** | $**—** | $**335954** |
| YTD gross write-offs | $— | $— | $— | $— | $— | $— | $— | $— | $— |
| **Commercial real estate loans** |  |  |  |  |  |  |  |  |  |
| Pass/Watch | $1909540 | $1286856 | $1673226 | $1442872 | $1290175 | $2184774 | $206139 | $— | $9993582 |
| Special Mention | 29745 | 58491 | 74142 | 113065 | 32074 | 33062 | 22214 |  | 362793 |
| Substandard | 2589 | 15069 | 11520 | 26772 | 59915 | 63004 | 1724 | 1208 | 181801 |
| Doubtful |  |  |  |  |  | 17843 |  |  | 17843 |
| **Total** | $**1941874** | $**1360416** | $**1758888** | $**1582709** | $**1382164** | $**2298683** | $**230077** | $**1208** | $**10556019** |
| YTD gross write-offs | $— | $— | $— | $— | $930 | $3632 | $— | $— | $4562 |
| **Residential mortgage loans** |  |  |  |  |  |  |  |  |  |
| Pass/Watch | $980403 | $488518 | $899547 | $905719 | $688469 | $1826904 | $— | $— | $5789560 |
| Special Mention |  |  |  |  |  | 1571 |  |  | 1571 |
| Substandard | 47 | 2140 | 5252 | 7585 | 4764 | 20801 |  |  | 40589 |
| **Total** | $**980450** | $**490658** | $**904799** | $**913304** | $**693233** | $**1849276** | $**—** | $**—** | $**5831720** |
| YTD gross write-offs | $— | $74 | $— | $— | $— | $— | $— | $— | $74 |
| **Equity lines** |  |  |  |  |  |  |  |  |  |
| Pass/Watch | $— | $— | $— | $— | $— | $— | $209256 | $15853 | $225109 |
| Special Mention |  |  |  |  |  |  |  |  |  |
| Substandard |  |  |  |  |  |  | 1494 | 436 | 1930 |
| **Total** | $**—** | $**—** | $**—** | $**—** | $**—** | $**—** | $**210750** | $**16289** | $**227039** |
| YTD gross write-offs | $— | $— | $— | $— | $— | $— | $— | $— | $— |
| **Installment and other loans** |  |  |  |  |  |  |  |  |  |
| Pass/Watch | $1635 | $108 | $— | $71 | $— | $— | $— | $— | $1814 |
| **Total** | $**1635** | $**108** | $**—** | $**71** | $**—** | $**—** | $**—** | $**—** | $**1814** |
| YTD gross write-offs | $— | $— | $— | $— | $— | $— | $— | $— | $— |
| **Total loans** | $**3411331** | $**2146605** | $**2947859** | $**2725330** | $**2297334** | $**4255068** | $**2323975** | $**24797** | $**20132299** |
| **Total YTD gross write-offs** | $**—** | $**249** | $**715** | $**2752** | $**5399** | $**16135** | $**12487** | $**—** | $**37737** |

---

**Allowance for Credit Losses**

The Company has an allowance framework under ASC Topic *326* for all financial assets measured at amortized cost and certain off-balance sheet credit exposures. The measurement of the allowance for credit losses is based on management's best estimate of lifetime expected credit losses inherent in the Company's relevant financial assets. The forward-looking concept of current expected credit loss ("CECL") approach requires loss estimates to consider historical experience, current conditions and reasonable and supportable economic forecasts of future events and circumstances.

The ACL is the combination of the allowance for loan losses and the reserve for unfunded loan commitments. The allowance for loan losses is reported as a reduction of the amortized cost basis of loans, while the reserve for unfunded loan commitments is included within "other liabilities" on the Consolidated Balance Sheets (Unaudited). The amortized cost basis of loans does *not* include accrued interest receivable, which is included in "accrued interest receivable" on the Consolidated Balance Sheets. The "Provision for credit losses" on the Consolidated Statements of Operations and Comprehensive Income (Unaudited) is a combination of the provision for loan losses and the provision for unfunded loan commitments.

Management estimates expected credit losses using a combination of historical loss experience, internal credit risk metrics, borrower-specific information, and external economic forecasts. Historical loss data accounts for portfolio composition, delinquency trends, and other relevant credit indicators. The Company incorporates forward-looking information by applying reasonable and supportable forecasts of key macroeconomic variables, including GDP, unemployment rates, and real estate market conditions, which are updated regularly and applied consistently across loan portfolios.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *13*

------

[**Table of Contents**](#toc)

Under the CECL methodology, quantitative and qualitative loss factors are applied to our population of loans on a collective pool basis when similar risk characteristics exist. Loans that do *not* share similar risk characteristics with pooled loans include loans individually evaluated due to credit deterioration, borrower-specific circumstances and loan modifications made to borrowers experiencing financial difficulty. Expected credit losses for individually evaluated loans are measured using discounted expected cash flows or, for collateral-dependent loans, the fair value of collateral less estimated costs to sell.

Quantitative Factors

The Company evaluates expected credit losses for loan pools with similar risk characteristics using quantitative models that incorporate historical loss experience, borrower credit attributes, collateral characteristics, and projected economic conditions. Loan portfolios are segmented into groups such as residential mortgages, commercial and industrial loans, construction loans, and various classes of commercial real estate based on common risk characteristics. The quantitative models estimate lifetime expected credit losses by considering contractual cash flows and expected prepayments, and the impact of forecasted macroeconomic conditions.

The quantitative framework generally considers the probability that a borrower will default ("probability of default" or PD), the expected severity of loss in the event of default ("loss given default" or LGD), and the expected exposure at the time of default ("exposure at default" or EAD). These components are influenced by historical performance, loan structure, collateral type, and forecasted macroeconomic conditions. The models estimate lifetime expected credit losses by considering contractual cash flows and expected prepayments, and the impact of forecasted economic conditions.

The Company applies an *eight* quarter reasonable and supportable forecast period followed by a *four* quarter systematic reversion to long-term historical loss experience. Multiple economic scenarios *may* be considered in developing the forecast, and management applies judgment in determining the weighting of those scenarios.

Expected credit losses are estimated over the contractual term of the loans, adjusted for expected prepayments. The contractual term excludes expected extensions, renewals, and modifications unless such options are included in the original or modified contract and are *not* unconditionally cancellable by the Company.

For certain smaller portfolios with limited historical loss experience, such as SBA loans and, HELOCs, the Company applies a simplified loss-rate approach that incorporates historical performance, forecasted economic conditions, and reversion to long-term loss expectations.

Qualitative Factors

The Company applies qualitative adjustments to reflect factors *not* fully captured in the quantitative models, including changes in underwriting practices, borrower concentrations, subportfolio growth, competitive dynamics, regulatory developments, and economic uncertainty. Qualitative adjustments also consider emerging risks, model limitations, and credit trends *not* yet observable in historical data, as well as collateral value considerations for certain loan types.

The Company's CECL methodology requires a significant amount of management judgment in determining the appropriate allowance for credit losses. Several of the steps in the methodology involve judgment and are subjective in nature including, among other things:

● Segmenting the loan portfolio

● Determining the amount of loss history to consider

● Evaluating model inputs, assumptions, and data sources

● Assessing expected prepayment behavior

● Selecting and weighting the most appropriate reasonable and supportable economic forecast scenario

● Determining the length and structure of the R&S forecast and reversion periods

● Estimating expected utilization rates on unfunded loan commitments

● Assessing relevant and appropriate qualitative factors.

In addition, the CECL methodology is dependent on economic forecasts that are inherently imprecise and will change from period to period. Although the allowance for credit losses is considered by management to be appropriate, there can be *no* assurance that it will be sufficient to absorb future losses.

Management believes the allowance for credit losses is appropriate based on the Company's loan portfolio, associated unfunded commitments, credit risk ratings, and other relevant information available.

Individually Evaluated Loans

When a loan *no* longer shares similar risk characteristics with other loans, such as in the case of certain nonaccrual loans, the Company estimates the allowance for loan losses on an individual loan basis. Generally, the allowance for loan losses for individually evaluated loans is measured as the difference between the recorded value of the loans and the fair value of the collateral. For loans evaluated individually, the Company uses *one* of *two* different asset valuation measurement methods: (*1*) the fair value of collateral less costs to sell; or (*2*) the present value of expected future cash flows. If an individually evaluated loan is determined to be collateral dependent, the Company applies the fair value of the collateral less costs to sell method. If an individually evaluated loan is determined *not* to be collateral dependent, the Company uses the present value of future cash flows.

Unfunded Loan Commitments

Unfunded loan commitments are generally related to providing credit facilities to clients of the Bank and are *not* actively traded financial instruments. These unfunded commitments are disclosed as off-balance sheet financial instruments in Note *10* in the Notes to Consolidated Financial Statements (Unaudited).

The Company estimates expected credit losses over the contractual period in which the Company is exposed to credit risk via a contractual obligation to extend credit, unless that obligation is unconditionally cancellable by the Company, using the same loss factors as used for the allowance for loan losses. The reserve for unfunded loan commitments uses a *one*-year historical usage rate of the unfunded commitments during the contractual life of the commitments. The allowance for unfunded commitments is included in "other liabilities" on the Consolidated Balance Sheets. Changes in the allowance for unfunded commitments are included in the provision for credit losses.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *14*

------

[**Table of Contents**](#toc)

The following tables set forth activity in the allowance for loan losses and allowance for unfunded commitments by portfolio segment for the *three* months ended *March 31, 2026*, and *March 31, 2025*.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  |  |  |  | ***Residential*** |  |  |
|  |  |  | ***Commercial*** | ***Mortgage Loans*** | ***Installment*** |  |
|  | ***Commercial*** | ***Construction*** | ***Real Estate*** | ***and*** | ***and Other*** |  |
|  | ***Loans*** | ***Loans*** | ***Loans*** | ***Equity Lines*** | ***Loans*** | ***Total*** |
|  | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) |
| **Allowance for Loan Losses:** |  |  |  |  |  |  |
| **December 31, 2025 Ending Balance** | $39123 | $6475 | $125665 | $24641 | $7 | $195911 |
| Provision/(reversal) for expected credit losses | 10637 | 8929 | (4267) | (310) | 9 | 14998 |
| Charge-offs | (7971) |  | (1368) | (17) |  | (9356) |
| Recoveries | 4931 |  | 2302 |  |  | 7233 |
| Net (charge-offs)/recoveries | (3040) |  | 934 | (17) |  | (2123) |
| **March 31, 2026 Ending Balance** | $**46720** | $**15404** | $**122332** | $**24314** | $**16** | $**208786** |
| **Allowance for unfunded credit commitments:** |  |  |  |  |  |  |
| **December 31, 2025 Ending Balance** | $9067 | $3095 | $279 | $— | $— | $12441 |
| Provision/(reversal) for expected credit losses | 3749 | (334) | (220) |  |  | 3195 |
| **March 31, 2026 Ending Balance** | $**12816** | $**2761** | $**59** | $**—** | $**—** | $**15636** |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  |  |  |  | ***Residential*** |  |  |
|  |  |  | ***Commercial*** | ***Mortgage Loans*** | ***Installment*** |  |
|  | ***Commercial*** | ***Construction*** | ***Real Estate*** | ***and*** | ***and Other*** |  |
|  | ***Loans*** | ***Loans*** | ***Loans*** | ***Equity Lines*** | ***Loans*** | ***Total*** |
|  | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) |
| **Allowance for Loan Losses:** |  |  |  |  |  |  |
| **December 31, 2024 Ending Balance** | $57796 | $8185 | $79597 | $16181 | $6 | $161765 |
| Provision/(reversal) for expected credit losses | 13301 | 355 | 1214 | (733) | 11 | 14148 |
| Charge-offs | (2344) |  |  |  |  | (2344) |
| Recoveries | 270 |  | 90 | 7 |  | 367 |
| Net (charge-offs)/recoveries | (2074) |  | 90 | 7 |  | (1977) |
| **March 31, 2025 Ending Balance** | $**69023** | $**8540** | $**80901** | $**15455** | $**17** | $**173936** |
| **Allowance for unfunded credit commitments:** |  |  |  |  |  |  |
| **December 31, 2024 Ending Balance** | $7780 | $1896 | $— | $— | $— | $9676 |
| Provision for expected credit losses | 1277 | 75 |  |  |  | 1352 |
| **March 31, 2025 Ending Balance** | $**9057** | $**1971** | $**—** | $**—** | $**—** | $**11028** |

---

During the *three* months ended *March 31, 2026*, the Company transferred $6.9 million in commercial loans held for investment to loans held for sale. Loans transferred to held-for-sale are recorded at the lower of cost or fair value, with any write-down recognized through the allowance for credit losses. There were no loan sales during the *three* months ended *March 31, 2026*.

<u>***7.* Equity Securities***</u>

As of *March 31, 2026,* and *December 31, 2025,* equity securities had a carrying value of $69.2 million and $51.9 million, including certain equity securities with a fair value $26.6 million and $32.8 million, respectively, which are valued using quoted prices in active markets. The remaining balance of equity securities consists of investments in private investment funds. The Company recognized an unrealized net gain of $17.3 million for the *three* months ending *March 31, 2026,* compared to an unrealized net loss of $4.2 million for the *three* months ending *March 31, 2025.* The $21.5 million increase in unrealized gain was due to an increase in the value of equity investments during the *three* months ending *March 31, 2026,* when compared to the *three* months ending *March 31, 2025.* 

***<u>*8.* Goodwill and Other Intangible Assets</u>***

*Goodwill.* Total goodwill was $375.7 million as of *March 31, 2026*, and remains unchanged compared with *December 31, 2025*. The Company completed its annual goodwill impairment testing and concluded that goodwill was not impaired as of *December 31, 2025*. Management has identified *no* interim events or changes in circumstances that would indicate potential impairment.

*Core Deposit Intangibles.*

The following table presents the gross carrying amount and accumulated amortization of core deposits intangible assets as of *March 31, 2026*, and *December 31, 2025*:

---

| | | |
|:---|:---|:---|
|  | ***March 31, 2026*** | ***December 31, 2025*** |
|  | ($ In thousands) | ($ In thousands) |
| Gross balance | $9260 | $9260 |
| Accumulated amortization | (6154) | (5936) |
| Impairment | (1324) | (1324) |
| **Net carrying balance** | $**1782** | $**2000** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *15*

------

[**Table of Contents**](#toc)

There were no impairment write-downs included in amortization of core deposit intangibles for the *three* months ended *March 31, 2026*, and *March 31, 2025*.

The Company amortizes the core deposit intangibles based on the projected useful lives of the related deposits. The amortization expense related to the core deposit intangible assets was $218 thousand and $250 thousand for the *three* months ended *March 31, 2026*, and *2025*, respectively.

The following table presents the estimated aggregate amortization expense of core deposit intangibles for each of the remaining years:

---

| | |
|:---|:---|
|  | ***Amount*** |
|  | ($ In thousands) |
| 2026 | $653 |
| 2027 | 870 |
| 2028 | 259 |
| **Total** | $**1782** |

---

***<u>*9.* Borrowed Funds</u>***

*Borrowings from the Federal Home Loan Bank (*"*FHLB*"*)* – There were no over-night borrowings from the FHLB as of *March 31, 2026*, and *December 31, 2025*. There were no advances from the FHLB as of *March 31, 2026*, and *December 31, 2025*. Our unused borrowing capacity from the FHLB as of *March 31, 2026*, and *December 31, 2025*, was $7.95 billion and $7.89 billion, respectively, and unpledged securities at *March 31, 2026*, and *December 31, 2025*, was $1.66 billion and $1.64 billion, respectively.

*Long Term Debt* – The Company established *three* special purpose trusts in *2003* and *two* in *2007* for the purpose of issuing Guaranteed Preferred Beneficial Interests in their Subordinated Debentures to outside investors ("Capital Securities"). The proceeds from the issuance of the Capital Securities as well as our purchase of the common stock of the special purpose trusts were invested in Junior Subordinated Notes of the Company ("Junior Subordinated Notes"). The trusts exist for the purpose of issuing Capital Securities and investing in Junior Subordinated Notes. Subject to some limitations, payment of distributions out of the monies held by the trusts and payments on liquidation of the trusts, or the redemption of the Capital Securities, are guaranteed by the Company to the extent the trusts have funds on hand at such time. The obligations of the Company under the guarantees and the Junior Subordinated Notes are subordinate and junior in right of payment to all indebtedness of the Company and are structurally subordinated to all liabilities and obligations of the Company's subsidiaries. The Company has the right to defer payments of interest on the Junior Subordinated Notes at any time or from time to time for a period of up to *twenty* consecutive quarterly periods with respect to each deferral period. Under the terms of the Junior Subordinated Notes, the Company *may not,* with certain exceptions, declare or pay any dividends or distributions on its capital stock or purchase or acquire any of its capital stock if it has deferred payment of interest on any Junior Subordinated Notes.

At *March 31, 2026*, Junior Subordinated Notes totaled $119.1 million with a weighted average interest rate of 6.23%, compared to $119.1 million with a weighted average rate of 6.76% at *December 31, 2025*. The Junior Subordinated Notes have a stated maturity term of 30 years.

***<u>*10.* Commitments and Contingencies</u>***

From time to time, Bancorp and its subsidiaries are parties to litigation that arises in the ordinary course of business or otherwise is incidental to various aspects of its operations. Based upon information available to the Company and its review of any such litigation with counsel, management presently believes that the liability relating to such litigation, if any, would *not* be expected to have a material adverse impact on the Company's consolidated financial condition, results of operations or liquidity taken as a whole. The outcome of litigation and other legal and regulatory matters is inherently uncertain, however, and it is possible that *one* or more of the legal matters currently pending or threatened against the Company could have a material adverse effect on the Company's consolidated financial condition, results of operations or liquidity taken as a whole.

Although the Company establishes accruals for legal proceedings when information related to the loss contingencies represented by those matters indicates both that a loss is probable and that the amount of loss can be reasonably estimated, the Company does *not* have accruals for all legal proceedings where there is a risk of loss. In addition, amounts accrued *may not* represent the ultimate loss to the Company from the legal proceedings in question. Thus, ultimate losses *may* be higher or lower, and possibly significantly so, than the amounts accrued for legal loss contingencies.

In the normal course of business, the Company from time to time becomes a party to financial instruments with off-balance sheet risk to meet the financing needs of its clients. These financial instruments include commitments to extend credit in the form of loans, or through commercial or standby letters of credit and financial guarantees. These instruments represent varying degrees of exposure to risk in excess of the amounts included in the accompanying Consolidated Balance Sheets. The contractual or notional amount of these instruments indicates a level of activity associated with a particular class of financial instrument and is *not* a reflection of the level of expected losses, if any.

The Company's unfunded commitments related to investments in qualified affordable housing and alternative energy partnerships were $85.5 million and $89.3 million as of *March 31, 2026*, and *December 31, 2025*, respectively.

*Loan Commitments* - We enter into contractual commitments to extend credit, normally with fixed expiration dates or termination clauses, at specified rates and for specific purposes. Substantially all of our commitments to extend credit are contingent upon clients maintaining specific credit standards at the time of loan funding. We minimize our exposure to loss under these commitments by subjecting them to credit approval and monitoring procedures. Management assesses the credit risk associated with certain commitments to extend credit in determining the level of the allowance for credit losses.

*Standby Letters of Credit* - Standby letters of credit are written conditional commitments issued by us to secure the obligations of a client to a *third* party. In the event the client does *not* perform in accordance with the terms of an agreement with the *third* party, we would be required to fund the commitment. The maximum potential amount of future payments we could be required to make is represented by the contractual amount of the commitment. If the commitment is funded, we would be entitled to seek reimbursement from the client. Our policies generally require that standby letter of credit arrangements contain security and debt covenants similar to those contained in loan agreements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *16*

------

[**Table of Contents**](#toc)

As of *March 31, 2026* and *December 31, 2025,* commitments to extend credit of $3.95 and $3.81 billion include commitments to fund fixed rate loans of $52.7 and $48.4 million and adjustable-rate loans of $3.90 and $3.76 billion, respectively.

***<u>*11.* Stockholders</u>***<u>'</u>***<u>Equity</u>***

Total equity was $2.99 billion as of *March 31, 2026*, an increase of $61.3 million, from $2.93 billion as of *December 31, 2025*, primarily due to net income of $86.9 million, other comprehensive income of $10.2 million, stock-based compensation of $1.6 million, and proceeds from dividend reinvestment of $0.7 million, offset by common stock cash dividends of $25.4 million, and purchase of treasury stock of $12.6 million.

Activity in accumulated other comprehensive income/(loss), net of tax, and reclassification out of accumulated other comprehensive income/(loss) for the *three* months ended *March 31, 2026*, and *March 31, 2025*, was as follows:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | ***Three Months Ended March 31, 2026*** | ***Three Months Ended March 31, 2026*** | ***Three Months Ended March 31, 2026*** | ***Three Months Ended March 31, 2025*** | ***Three Months Ended March 31, 2025*** | ***Three Months Ended March 31, 2025*** |
|  | ***Pre-tax*** | ***Tax expense*** | ***Net-of-tax*** | ***Pre-tax*** | ***Tax expense*** | ***Net-of-tax*** |
|  | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) |
| **Beginning balance, loss, net of tax** |  |  |  |  |  |  |
| Securities AFS |  |  | $(54400) |  |  | $(85607) |
| Total |  |  | $**(54400)** |  |  | $**(85607)** |
| Net unrealized (losses)/ gains on AFS securities arising during the period | (1173) | (346) | (827) | 19676 | 5816 | 13860 |
| Reclassification adjustment for net losses on AFS securities in net income | 15685 | 4636 | 11049 | **-** | **-** | **-** |
| **Ending balance, loss, net of tax** |  |  |  |  |  |  |
| Securities AFS |  |  | $(44178) |  |  | $(71747) |
| Total |  |  | $**(44178)** |  |  | $**(71747)** |

---

***<u>*12.* Earnings per Share</u>***

Basic earnings per share excludes dilution and is computed by dividing net income available to common stockholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per common share reflects the potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock and resulted in the issuance of common stock that then shared in earnings. Restricted stock units ("RSUs") with anti-dilutive effect were *not* included in the computation of diluted earnings per share. The following table sets forth earnings per common share calculations:

---

| | | |
|:---|:---|:---|
|  | ***Three Months Ended March 31,*** | ***Three Months Ended March 31,*** |
| ($ In thousands, except share and per share data) | *2026* | *2025* |
| Net income | $86886 | $69506 |
| Weighted-average shares: |  |  |
| Basic weighted-average number of common shares outstanding | 67040473 | 70379835 |
| Dilutive effect of weighted-average outstanding common share equivalents: |  |  |
| RSUs | 347184 | 299805 |
| **Diluted weighted-average number of common shares outstanding** | **67387657** | **70679640** |
| Average restricted stock units with anti-dilutive effect | 640 | 42622 |
| Earnings per common share: |  |  |
| Basic | $1.30 | $0.99 |
| Diluted | $1.29 | $0.98 |

---

***<u>*13.* Stock-Based Compensation</u>***

Pursuant to the Company's *2005* Incentive Plan, as amended and restated, the Company *may* grant incentive stock options (employees only), non-statutory stock options, common stock awards, restricted stock, RSUs, stock appreciation rights and cash awards to non-employee directors and eligible employees.

RSUs are generally granted at *no* cost to the recipient. RSUs generally vest ratably over three years or cliff vest after one or three years of continued employment from the date of the grant. While a portion of RSUs *may* be time-vesting awards, others *may* vest subject to the attainment of specified performance goals and are referred to as "performance-based RSUs." All RSUs are subject to forfeiture until vested.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *17*

------

[**Table of Contents**](#toc)

Performance-based RSUs are granted at the target amount of awards. Based on the Company's attainment of specified performance goals and consideration of market conditions, the number of shares that vest can be adjusted to a minimum of zero and to a maximum of 150% of the target. The amount of performance-based RSUs that are eligible to vest is determined at the end of each performance period and is then added together to determine the total number of performance shares that are eligible to vest. Performance-based RSUs generally cliff vest three years from the date of grant.

Compensation costs for the time-based awards are based on the quoted market price of the Company's stock at the grant date. Compensation costs associated with performance-based RSUs are based on grant date fair value, which considers both market and performance conditions. Compensation costs of both time-based and performance-based awards are recognized on a straight-line basis from the grant date until the vesting date of each grant.

The following table presents RSU activity during the *three* months ended *March 31, 2026*:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | ***Time-Based RSUs*** | ***Time-Based RSUs*** | ***Performance-Based RSUs*** | ***Performance-Based RSUs*** |
|  |  | ***Weighted-Average*** |  | ***Weighted-Average*** |
|  |  | ***Grant Date*** |  | ***Grant Date*** |
|  | ***Shares*** | ***Fair Value*** | ***Shares*** | ***Fair Value*** |
| **Balance at December 31, 2025** | 210701 | $34.70 | 313031 | $33.02 |
| Granted | 2468 | 48.61 |  | 46.00 |
| Vested | (1756) | 52.47 |  | 42.82 |
| Forfeited | (3166) | 40.50 |  | 37.91 |
| **Balance at March 31, 2026** | **208247** | $**34.63** | **313031** | $**33.02** |

---

The compensation expense recorded for RSUs was $1.6 million and $1.5 million for the *three* months ended *March 31, 2026*, and *2025*, respectively. Unrecognized stock-based compensation expense related to RSUs was $8.0 million and $8.1 million as of *March 31, 2026*, and *2025*, respectively. As of *March 31, 2026*, these costs are expected to be recognized over the next 1.7 years for time-based and performance-based RSUs.

As of *March 31, 2026*, 2,812,469 shares were available for future grants under the Company's *2005* Incentive Plan, as amended and restated.

***<u>*14.* Income Taxes</u>***

The effective tax rate for the *first three* months of *2026* was 21.0% compared to 19.8% for the *first three* months of *2025*. The effective tax rate for the *first three* months of *2026* includes the impact of low-income housing tax credits and for the *first three* months of *2025* includes the impact of alternative energy investment and low-income housing tax credits.

The Company's tax returns are open for audit by the Internal Revenue Service back to 2023 and by the California Franchise Tax Board and other states where the Company files state tax returns back to 2022.

It is reasonably possible that unrecognized tax benefits could change significantly over the next *twelve* months. The Company does *not* expect that any such changes would have a material impact on its annual effective tax rate.

***<u>*15.* Fair Value Measurements and Fair Value of Financial Instruments</u>***

The Company uses fair value to measure certain assets and liabilities on a recurring basis, primarily securities available-for-sale and derivatives. For assets measured at the lower of cost or fair value, the fair value measurement criteria *may* or *may not* be met during a reporting period and such measurements are therefore considered "nonrecurring" for purposes of disclosing our fair value measurements. Fair value is used on a nonrecurring basis to adjust carrying values for individually evaluated loans and other real estate owned and also to record impairment on certain assets, such as goodwill, CDI, and other long-lived assets.

The Company used valuation methodologies to measure assets at fair value under ASC Topic *820* and ASC Topic *825,* as amended by ASU *2016*-*01* and ASU *2018*-*03,* to estimate the fair value of financial instruments *not* recorded at fair value. The fair value of the Company's assets and liabilities is classified and disclosed in *one* of the following *three* categories:

● Level *1* – Quoted prices in active markets for identical assets or liabilities.

● Level *2* – Observable prices in active markets for similar assets or liabilities; prices for identical or similar assets or liabilities in markets that are *not* active; directly observable market inputs for substantially the full term of the asset and liability; market inputs that are *not* directly observable but are derived from or corroborated by observable market data.

● Level *3* – Unobservable inputs based on the Company's own judgment about the assumptions that a market participant would use.

The classification of assets and liabilities within the hierarchy is based on whether inputs to the valuation methodology used are observable or unobservable, and the significance of those inputs in the fair value measurement. The Company's assets and liabilities are classified in their entirety based on the lowest level of input that is significant to their fair value measurements.

*Financial assets and liabilities measured at fair value on a recurring basis:*

The Company uses the following methodologies to measure the fair value of its financial assets and liabilities on a recurring basis:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *18*

------

[**Table of Contents**](#toc)

*Securities Available-for-Sale and Equity Securities* - For certain actively traded agency preferred stocks, mutual funds, U.S. Treasury securities, and other equity securities, the Company measures the fair value based on quoted market prices in active exchange markets at the reporting date, a Level *1* measurement. The Company also measures securities by using quoted market prices for similar securities or dealer quotes, a Level *2* measurement. This category generally includes U.S. Government agency securities, U.S. Government sponsored entities, state and municipal securities, mortgage-backed securities ("MBS"), collateralized mortgage obligations and corporate bonds.

*Interest Rate Swaps* – The Company measures the fair value of interest rate swaps using *third* party models with observable market data, a Level *2* measurement.

*Currency Option Contracts and Foreign Exchange Contracts* - The Company measures the fair value of currency option contracts and foreign exchange contracts based on observable market rates on a recurring basis, a Level *2* measurement.

The following tables present financial assets and liabilities that are measured at fair value on a recurring basis as of *March 31, 2026*, and *December 31, 2025*:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | ***March 31, 2026*** | ***March 31, 2026*** | ***March 31, 2026*** |  |
|  | ***Fair Value Measurements Using*** | ***Fair Value Measurements Using*** | ***Fair Value Measurements Using*** | ***Total Fair Value*** |
|  | ***Level 1*** | ***Level 2*** | ***Level 3*** | ***Measurements*** |
|  | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) |
| **Assets** |  |  |  |  |
| Securities AFS |  |  |  |  |
| U.S. Treasury securities | $915950 | $— | $— | $915950 |
| U.S. government agency entities |  | 5020 |  | 5020 |
| Mortgage-backed securities |  | 607838 |  | 607838 |
| Collateralized mortgage obligations |  | 21986 |  | 21986 |
| Corporate debt securities |  | 127346 |  | 127346 |
| **Total securities AFS** | **915950** | **762190** |  | **1678140** |
| Equity securities |  |  |  |  |
| Mutual funds | 8646 |  |  | 8646 |
| Preferred stock of government sponsored entities | 7044 |  |  | 7044 |
| Other equity securities | 10927 |  |  | 10927 |
| **Total equity securities** | **26617** |  |  | **26617** |
| Interest rate swaps |  | 23668 |  | 23668 |
| Foreign exchange contracts |  | 675 |  | 675 |
| **Total assets** | $**942567** | $**786533** | $**—** | $**1729100** |
| **Liabilities** |  |  |  |  |
| Interest rate swaps | $— | $23596 | $— | $23596 |
| Foreign exchange contracts |  | 125 |  | 125 |
| **Total liabilities** | $**—** | $**23721** | $**—** | $**23721** |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | ***December 31, 2025*** | ***December 31, 2025*** | ***December 31, 2025*** |  |
|  | ***Fair Value Measurements Using*** | ***Fair Value Measurements Using*** | ***Fair Value Measurements Using*** | ***Total Fair Value*** |
|  | ***Level 1*** | ***Level 2*** | ***Level 3*** | ***Measurements*** |
|  | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) |
| **Assets** |  |  |  |  |
| Securities AFS |  |  |  |  |
| U.S. Treasury securities | $828193 | $— | $— | $828193 |
| U.S. government agency entities |  | 5822 |  | 5822 |
| U.S. government sponsored entities |  | 25011 |  | 25011 |
| Mortgage-backed securities |  | 629437 |  | 629437 |
| Collateralized mortgage obligations |  | 22748 |  | 22748 |
| Corporate debt securities |  | 147012 |  | 147012 |
| **Total securities AFS** | **828193** | **830030** |  | **1658223** |
| Equity securities |  |  |  |  |
| Mutual funds | 8691 |  |  | 8691 |
| Preferred stock of government sponsored entities | 9364 |  |  | 9364 |
| Other equity securities | 14699 |  |  | 14699 |
| **Total equity securities** | **32754** |  |  | **32754** |
| Interest rate swaps |  | 26472 |  | 26472 |
| Foreign exchange contracts |  | 211 |  | 211 |
| **Total assets** | $**860947** | $**856713** | $**—** | $**1717660** |
| **Liabilities** |  |  |  |  |
| Interest rate swaps | $— | $28917 | $— | $28917 |
| Foreign exchange contracts |  | 73 |  | 73 |
| **Total liabilities** | $**—** | $**28990** | $**—** | $**28990** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *19*

------

[**Table of Contents**](#toc)

*Financial assets and liabilities measured at estimated fair value on a non-recurring basis:*

Certain assets or liabilities are required to be measured at estimated fair value on a nonrecurring basis subsequent to initial recognition. Generally, these adjustments are the result of lower-of-cost-or-fair value or other impairment write-downs of individual assets. In determining the estimated fair values during the period, the Company determined that substantially all the changes in estimated fair value were due to declines in market conditions versus instrument specific credit risk.

For financial assets measured at fair value on a nonrecurring basis that were still reflected in the Consolidated Balance Sheets as of *March 31, 2026*, and *December 31, 2025*, the following tables set forth the level of valuation assumptions used to determine each adjustment, the carrying value of the related individual assets as of *March 31, 2026*, and *December 31, 2025*, and the total losses for the periods indicated:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | ***As of March 31, 2026*** | ***As of March 31, 2026*** | ***As of March 31, 2026*** | ***As of March 31, 2026*** | ***Total Losses*** | ***Total Losses*** |
|  | ***Fair Value Measurements Using*** | ***Fair Value Measurements Using*** | ***Fair Value Measurements Using*** | ***Total Fair Value*** | ***For the Three Months Ended*** | ***For the Three Months Ended*** |
|  | ***Level 1*** | ***Level 2*** | ***Level 3*** | ***Measurements*** | ***March 31, 2026*** | ***March 31, 2025*** |
|  | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) |
| **Assets** |  |  |  |  |  |  |
| Non-accrual loans by type: |  |  |  |  |  |  |
| Commercial loans | $— | $— | $25 | $25 | $— | $— |
| Commercial real estate loans |  |  | 17965 | 17965 | 971 |  |
| Residential mortgage loans and equity lines |  |  | 209 | 209 |  |  |
| Total non-accrual loans |  |  | 18199 | 18199 | 971 |  |
| Other real estate owned <sup>(1)</sup> |  |  | 35518 | 35518 |  |  |
| Other equity securities |  |  | 1539 | 1539 |  |  |
| Investments in venture capital |  |  | 84 | 84 |  |  |
| **Total assets** | $**—** | $**—** | $**55340** | $**55340** | $**971** | $**—** |
| <sup>(1)</sup> Other real estate owned balance of $33.4 million in the Consolidated Balance Sheets is net of estimated disposal costs. | <sup>(1)</sup> Other real estate owned balance of $33.4 million in the Consolidated Balance Sheets is net of estimated disposal costs. | <sup>(1)</sup> Other real estate owned balance of $33.4 million in the Consolidated Balance Sheets is net of estimated disposal costs. | <sup>(1)</sup> Other real estate owned balance of $33.4 million in the Consolidated Balance Sheets is net of estimated disposal costs. | <sup>(1)</sup> Other real estate owned balance of $33.4 million in the Consolidated Balance Sheets is net of estimated disposal costs. | <sup>(1)</sup> Other real estate owned balance of $33.4 million in the Consolidated Balance Sheets is net of estimated disposal costs. | <sup>(1)</sup> Other real estate owned balance of $33.4 million in the Consolidated Balance Sheets is net of estimated disposal costs. |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | ***As of December 31, 2025*** | ***As of December 31, 2025*** | ***As of December 31, 2025*** | ***As of December 31, 2025*** | ***Total Losses*** | ***Total Losses*** |
|  | ***Fair Value Measurements Using*** | ***Fair Value Measurements Using*** | ***Fair Value Measurements Using*** | ***Total Fair Value*** | ***For the Twelve Months Ended*** | ***For the Twelve Months Ended*** |
|  | ***Level 1*** | ***Level 2*** | ***Level 3*** | ***Measurements*** | ***December 31, 2025*** | ***December 31, 2024*** |
|  | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) |
| **Assets** |  |  |  |  |  |  |
| Non-accrual loans by type: |  |  |  |  |  |  |
| Commercial loans | $— | $— | $1030 | $1030 | $6395 | $5654 |
| Commercial real estate loans |  |  | 28356 | 28356 | 4562 | 4049 |
| Residential mortgage loans and equity lines |  |  | 217 | 217 |  | 59 |
| Total non-accrual loans |  |  | 29603 | 29603 | 10957 | 9762 |
| Other real estate owned <sup>(1)</sup> |  |  | 32356 | 32356 |  |  |
| Other equity securities |  |  | 1539 | 1539 |  |  |
| Investments in venture capital |  |  | 84 | 84 | 2 | 147 |
| **Total assets** | $**—** | $**—** | $**63582** | $**63582** | $**10959** | $**9909** |
| <sup>(1)</sup> Other real estate owned balance of $30.3 million in the Consolidated Balance Sheets is net of estimated disposal costs. | <sup>(1)</sup> Other real estate owned balance of $30.3 million in the Consolidated Balance Sheets is net of estimated disposal costs. | <sup>(1)</sup> Other real estate owned balance of $30.3 million in the Consolidated Balance Sheets is net of estimated disposal costs. | <sup>(1)</sup> Other real estate owned balance of $30.3 million in the Consolidated Balance Sheets is net of estimated disposal costs. | <sup>(1)</sup> Other real estate owned balance of $30.3 million in the Consolidated Balance Sheets is net of estimated disposal costs. | <sup>(1)</sup> Other real estate owned balance of $30.3 million in the Consolidated Balance Sheets is net of estimated disposal costs. | <sup>(1)</sup> Other real estate owned balance of $30.3 million in the Consolidated Balance Sheets is net of estimated disposal costs. |

---

The significant unobservable (Level *3*) inputs used in the fair value measurement of collateral for collateral-dependent individually evaluated loans are primarily based on the appraised value of collateral adjusted by estimated sales cost and commissions. The Company generally obtains new appraisal reports every *twelve* months as appropriate. As the Company's primary objective in the event of default would be to monetize the collateral to settle the outstanding balance of the loan, less marketable collateral would receive a larger discount. In the current year, the Company used borrower specific collateral discounts with various discount levels.

The fair value of individually evaluated loans is calculated based on the net realizable fair value of the collateral or the observable market price of the most recent sale or quoted price from loans held for sale. The Company does *not* record loans at fair value on a recurring basis. Nonrecurring fair value adjustments to collateral dependent individually evaluated loans are recorded based on the current appraised value of the collateral, management's judgment and estimation of value using discounted future cash flows or old appraisals which are then adjusted based on recent market trends, a Level *3* measurement.

Loans held for sale are recorded at the lower of cost or fair value upon transfer. Loans held for sale *may* be measured at fair value on a nonrecurring basis when fair value is less than cost. Fair value is generally determined based on available market data for similar loans and therefore, are classified as Level *2* measurement.

The significant unobservable inputs (Level *3*) used in the fair value measurement of other real estate owned ("OREO") are primarily based on the appraised value of OREO adjusted by estimated sales cost and commissions. The Company applies estimated sales cost and commissions of 5% of the collateral value of individually evaluated loans, quoted price, or loan sale price of loans held for sale, and appraised value of OREO.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *20*

------

[**Table of Contents**](#toc)

Fair value is estimated in accordance with ASC Topic *825.* Fair value estimates are made at specific points in time, based on relevant market information and information about the financial instrument. These estimates do *not* reflect any premium or discount that could result from offering for sale at *one* time the Bank's entire holdings of a particular financial instrument. Because *no* market exists for a significant portion of the Bank's financial instruments, fair value estimates are based on judgments regarding future expected loss experience, current economic conditions, risk characteristics of various financial instruments, and other factors. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. Changes in assumptions could significantly affect the estimates.

The following table sets forth the carrying and notional amounts and estimated fair value of financial instruments as of *March 31, 2026*, and *December 31, 2025*:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | ***March 31, 2026*** | ***March 31, 2026*** | ***December 31, 2025*** | ***December 31, 2025*** |
|  | ***Carrying*** |  | ***Carrying*** |  |
|  | ***Amount*** | ***Fair Value*** | ***Amount*** | ***Fair Value*** |
|  | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) |
| **Financial Assets** |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Cash and due from banks | $135540 | $135540 | $146320 | $146320 |
| &nbsp;&nbsp;&nbsp; Short-term investments | 1069943 | 1069943 | 1278089 | 1278089 |
| &nbsp;&nbsp;&nbsp; Securities AFS | 1678140 | 1678140 | 1658223 | 1658223 |
| Loans held - for-sale | 6902 | 6902 |  |  |
| Loans held for investment, net | 19951639 | 20305000 | 19936388 | 20516176 |
| &nbsp;&nbsp;&nbsp; Equity securities | 69202 | 69202 | 51886 | 51886 |
| &nbsp;&nbsp;&nbsp; Investment in Federal Home Loan Bank stock | 17250 | 17250 | 17250 | 17250 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | ***Notional*** |  | ***Notional*** |  |
|  | ***Amount*** | ***Fair Value*** | ***Amount*** | ***Fair Value*** |
| &nbsp;&nbsp;&nbsp; Foreign exchange contracts | $194277 | $675 | $176037 | $211 |
| &nbsp;&nbsp;&nbsp; Interest rate swaps | 1303133 | 23668 | 1113823 | 26472 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | ***Carrying*** |  | ***Carrying*** |  |
|  | ***Amount*** | ***Fair Value*** | ***Amount*** | ***Fair Value*** |
| **Financial Liabilities** |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Deposits | $20675647 | $20649559 | $20894167 | $20884386 |
| &nbsp;&nbsp;&nbsp; Other borrowings | 13526 | 12659 | 17582 | 15394 |
| &nbsp;&nbsp;&nbsp; Long-term debt | 119136 | 82762 | 119136 | 79818 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | ***Notional*** |  | ***Notional*** |  |
|  | ***Amount*** | ***Fair Value*** | ***Amount*** | ***Fair Value*** |
| &nbsp;&nbsp;&nbsp; Foreign exchange contracts | $19498 | $125 | $37991 | $73 |
| &nbsp;&nbsp;&nbsp; Interest rate swaps | 1617808 | 23596 | 1590384 | 28917 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | ***Notional*** |  | ***Notional*** |  |
|  | ***Amount*** | ***Fair Value*** | ***Amount*** | ***Fair Value*** |
| **Off-Balance Sheet Financial Instruments** |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Commitments to extend credit | $3953659 | $(21958) | $3809999 | $(21357) |
| &nbsp;&nbsp;&nbsp; Standby letters of credit | 546559 | (2885) | 536745 | (2971) |
| &nbsp;&nbsp;&nbsp; Other letters of credit | 11526 | (11) | 4442 | (5) |

---

The following tables set forth the level in the fair value hierarchy for the estimated fair values of financial instruments as of *March 31, 2026*, and *December 31, 2025*, excluding financial instruments recorded at fair value on a recurring basis already presented in other tables in this note:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | ***As of March 31, 2026*** | ***As of March 31, 2026*** | ***As of March 31, 2026*** | ***As of March 31, 2026*** |
|  | ***Fair Value*** | ***Level 1*** | ***Level 2*** | ***Level 3*** |
|  | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) |
| **Financial Assets** |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Cash and due from banks | $135540 | $135540 | $— | $— |
| &nbsp;&nbsp;&nbsp; Short-term investments | 1069943 | 1069943 |  |  |
| &nbsp;&nbsp;&nbsp; Loans held for investment, net | 20305000 |  |  | 20305000 |
| Equity securities | 1539 |  |  | 1539 |
| &nbsp;&nbsp;&nbsp; Investment in Federal Home Loan Bank stock | 17250 |  | 17250 |  |
| **Financial Liabilities** |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Deposits | 20649559 |  |  | 20649559 |
| &nbsp;&nbsp;&nbsp; Other borrowings | 12659 |  |  | 12659 |
| &nbsp;&nbsp;&nbsp; Long-term debt | 82762 |  | 82762 |  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *21*

------

[**Table of Contents**](#toc)

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | ***As of December 31, 2025*** | ***As of December 31, 2025*** | ***As of December 31, 2025*** | ***As of December 31, 2025*** |
|  | ***Fair Value*** | ***Level 1*** | ***Level 2*** | ***Level 3*** |
|  | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) |
| **Financial Assets** |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Cash and due from banks | $146320 | $146320 | $— | $— |
| &nbsp;&nbsp;&nbsp; Short-term investments | 1278089 | 1278089 |  |  |
| &nbsp;&nbsp;&nbsp; Loans held for investment, net | 20516176 |  |  | 20516176 |
| Equity securities | 1539 |  |  | 1539 |
| &nbsp;&nbsp;&nbsp; Investment in Federal Home Loan Bank stock | 17250 |  | 17250 |  |
| **Financial Liabilities** |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Deposits | 20884386 |  |  | 20884386 |
| &nbsp;&nbsp;&nbsp; Other borrowings | 15394 |  |  | 15394 |
| &nbsp;&nbsp;&nbsp; Long-term debt | 79818 |  | 79818 |  |

---

***<u>*16.* Financial Derivatives</u>***

The Company uses derivative instruments to manage exposure to interest rate and foreign currency risk and to assist customers with their risk-management objectives. Certain derivatives are designated as hedging instruments in qualifying fair value hedge relationships. Other derivatives are economic hedges that do *not* qualify for, or the Company has elected *not* to apply, hedge accounting, including derivatives entered into to accommodate customer needs. Derivative instruments are recognized on the Consolidated Balance Sheets at fair value, and the accounting for changes in fair value depends on whether the derivative is designated as a hedging instrument.

*Customer Accommodation Derivatives (Economic Hedges)*

The Company enters into interest rate and foreign exchange derivative contracts with customers to assist them in managing market risks. For each customer derivative, the Company enters into an offsetting derivative with a third-party financial institution, including centrally cleared counterparties ("CCPs"), resulting in minimal net market risk to the Company. These derivatives are *not* designated as accounting hedges and are recorded at fair value, with changes in fair value recognized in earnings.

Certain derivatives cleared through CCPs are subject to daily variation margin. When variation margin is legally characterized as settlement under the CCP's rulebook, the daily cash exchanges are accounted for as settlements of the derivative's fair value rather than collateral.

As of *March 31, 2026*, and *December 31, 2025*, the Company had outstanding customer and offsetting dealer interest rate derivative contracts with a notional amount of $1.13 billion and $1.02 billion, respectively, fair values of $20.9 million and $24.0 million, respectively. As of *March 31, 2026*, and *December 31, 2025*, *no* customer swap transactions were cleared through a CCP.

The Company also enters into foreign exchange forward contracts with customers to mitigate the risk of fluctuations in foreign currency exchange rates associated with foreign currency deposits or customer-initiated foreign exchange transactions. These contracts are *not* designated as hedging instruments and are recorded at fair value, with changes in fair value recognized in non-interest income. Period-end gross positive fair values are recorded in other assets and gross negative fair values are recorded in other liabilities.

The notional amount and fair value of the Company's derivative financial instruments not designated as hedging instruments as of *March 31, 2026*, and *December 31, 2025*, *not* including interest rate swaps cleared through the CCP, were as follows:

---

| | | |
|:---|:---|:---|
| **Derivative financial instruments not designated as hedging instruments:** | **March 31, 2026** | **December 31, 2025** |
|  | ($ In thousands) | ($ In thousands) |
| **Notional amounts:** |  |  |
| Forward, and swap contracts with positive fair value | $1321666 | $1194638 |
| Forward, and swap contracts with negative fair value | $1146886 | $1056592 |
| **Fair value:** |  |  |
| Forward, and swap contracts with positive fair value | $21594 | $24199 |
| Forward, and swap contracts with negative fair value | $(21044) | $(24061) |

---

*Fair Value Hedges of Individual Loans*

As of *March 31, 2026*, the Bank's outstanding fair value interest rate swap contracts matched to individual fixed-rate commercial real estate loans with a notional amount of $47.1 million and a fair value of $1.6 million. These swaps are designated as fair value hedges of changes in the fair value of the underlying loans attributable to interest rate movements. The swaps amortize in line with the contractual amortization of the hedged loans and permit prepayments with the same prepayment penalty terms as the related loans. Hedge ineffectiveness for these relationships was *not* significant for the periods presented.

*Last*-*of*-*Layer (Portfolio Layer) Fair Value Hedges*

The Company has designated $577.3 million of notional amount as a last-of layer fair value hedge of closed pools of fixed-rate loans with an aggregate notional value of $869.3 million as of *March 31, 2026*. The loans included in the closed portfolio are expected to retain sufficient principal such that the hedged layer is *not* affected by prepayments, defaults, or other factors under the last-of-layer method.

The Company uses pay-fixed, receive *1-Month* Term SOFR interest rate swaps to hedge the designated last-of-layer portion of the loan pools. As of *March 31, 2026,* the hedged last-of-layer tranche had a fair value gain basis adjustment of $2.7 million. These swaps convert the hedged layer into a floating-rate exposure. The Company's objective in these hedging relationships is to reduce exposure to changes in fair value attributable to interest rate movements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *22*

------

[**Table of Contents**](#toc)

The notional amount and net unrealized loss of the Company's fair value derivative financial instruments as of *March 31, 2026*, and *December 31, 2025*, were as follows:

---

| | | |
|:---|:---|:---|
|  | ***March 31, 2026*** | ***December 31, 2025*** |
|  | ($ In thousands) | ($ In thousands) |
| **Fair value swap hedges:** |  |  |
| Notional | $624447 | $625222 |
| Weighted average fixed rate-pay | 3.83% | 4.06% |
| Weighted average variable rate spread | 0.18% | 0.19% |
| Weighted average variable rate-receive | 4.17% | 4.41% |
| Net gain/(loss)<sup>(1)</sup> | $0 | $(2417) |

---

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended** | **Three Months Ended** |
|  | **March 31, 2026** | **March 31, 2025** |
| Periodic net settlement of swaps <sup>(2)</sup> | $(534) | $1500 |
| <sup>(1)</sup> the amount is included in other non-interest income. | <sup>(1)</sup> the amount is included in other non-interest income. | <sup>(1)</sup> the amount is included in other non-interest income. |
| <sup>(2)</sup> the amount of periodic net settlement of interest rate swaps was included in interest income. | <sup>(2)</sup> the amount of periodic net settlement of interest rate swaps was included in interest income. | <sup>(2)</sup> the amount of periodic net settlement of interest rate swaps was included in interest income. |

---

Included in the total notional amount of $624.4 million of the fair value interest rate contracts entered into with financial counterparties as of *March 31, 2026*, was $570.8 million of interest rate swaps cleared through the CCP. Applying variation margin payments as settlement to CCP cleared derivative transactions resulted in a reduction in derivative asset fair values of $3.9 million as of *March 31, 2026*.

*Counterparty Credit Risk*

Derivative contracts expose the Company to the risk that counterparties *may* be unable to meet their contractual obligations. The Company manages this risk by transacting with institutional counterparties that have strong credit profiles and by requiring approval from the Bank's Board of Directors. Credit exposure is limited to the net favorable fair value and any accrued interest receivable on derivative positions. A significant portion of the Company's interest rate swaps are centrally cleared through a derivative clearing organization, which reduces counterparty credit risk.

***<u>*17.* Balance Sheet Offsetting</u>***

Certain financial instruments, including resell and repurchase agreements, securities lending arrangements and derivatives, *may* be eligible for offset in the Consolidated Balance Sheets and/or subject to master netting arrangements or similar agreements. The Company's securities sold with agreements to repurchase and derivative transactions with upstream financial institution counterparties are generally executed under International Swaps and Derivative Association master agreements that include "right of set-off" provisions. In such cases, there is generally a legally enforceable right to offset recognized amounts and there *may* be an intention to settle such amounts on a net basis. Nonetheless, the Company does *not* generally offset such financial instruments for financial reporting purposes.

Financial instruments that are eligible for offset in the Consolidated Balance Sheets, as of *March 31, 2026*, and *December 31, 2025*, are set forth in the following table:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  |  |  |  | ***Gross Amounts Not*** | ***Gross Amounts Not*** | ***Gross Amounts Not*** |
|  |  |  |  | ***Offset in the Balance Sheet*** | ***Offset in the Balance Sheet*** | ***Offset in the Balance Sheet*** |
|  | ***Gross Amounts Recognized*** | ***Gross Amounts Offset in the Balance Sheet*** | ***Net Amounts Presented in the Balance Sheet*** | ***Financial Instruments*** | ***Collateral Posted*** | ***Net Amount*** |
|  | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) |
| **March 31, 2026** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; **Assets:** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Derivatives | $23668 | $10330 | $13338 | $— | $837 | $12501 |
| &nbsp;&nbsp;&nbsp; **Liabilities:** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Derivatives | $23596 | $— | $23596 | $— | $— | $23596 |
| **December 31, 2025** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; **Assets:** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Derivatives | $26472 | $6089 | $20383 | $— | $1409 | $18974 |
| &nbsp;&nbsp;&nbsp; **Liabilities:** |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Derivatives | $28917 | $— | $28917 | $— | $— | $28917 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *23*

------

[**Table of Contents**](#toc)

***<u>*18.* Revenue from Contracts with Clients</u>***

The following is a summary of revenue from contracts with clients that are in-scope and *not* in-scope under ASC Topic *606:*

---

| | | |
|:---|:---|:---|
|  | ***Three Months Ended March 31,*** | ***Three Months Ended March 31,*** |
|  | ***2026*** | ***2025*** |
|  | ($ In thousands) | ($ In thousands) |
| **Non-interest income, in-scope:** |  |  |
| Fees and service charges on deposit accounts | $2679 | $2436 |
| Wealth management fees | 7102 | 6169 |
| Other service fees<sup>(1)</sup> | 4766 | 4483 |
| **Total in-scope non-interest income** | 14547 | 13088 |
| Non-interest gain/(loss), not in-scope(2) | 6112 | (1884) |
| **Total non-interest income** | $**20659** | $**11204** |
| <sup>(1)</sup> Other service fees comprise of fees related to letters of credit, wire fees, fees on foreign exchange transactions and other immaterial individual revenue streams. | <sup>(1)</sup> Other service fees comprise of fees related to letters of credit, wire fees, fees on foreign exchange transactions and other immaterial individual revenue streams. | <sup>(1)</sup> Other service fees comprise of fees related to letters of credit, wire fees, fees on foreign exchange transactions and other immaterial individual revenue streams. |
| <sup>(2)</sup> These amounts primarily represent revenue from contracts with clients that are out of the scope of ASC Topic 606 and primarily represent revenue from interest rate swap fees, unrealized gains and losses on equity securities and other miscellaneous income. | <sup>(2)</sup> These amounts primarily represent revenue from contracts with clients that are out of the scope of ASC Topic 606 and primarily represent revenue from interest rate swap fees, unrealized gains and losses on equity securities and other miscellaneous income. | <sup>(2)</sup> These amounts primarily represent revenue from contracts with clients that are out of the scope of ASC Topic 606 and primarily represent revenue from interest rate swap fees, unrealized gains and losses on equity securities and other miscellaneous income. |

---

The major revenue streams by fee type that are within the scope of ASC Topic *606* presented in the above table are described in additional detail below:

<u>Fees and Services Charges on Deposit Accounts</u>

Fees and service charges on deposit accounts include charges for analysis, overdraft, cash checking, ATM, and safe deposit activities executed by our deposit clients, as well as interchange income earned through card payment networks for the acceptance of card-based transactions. Fees earned from our deposit clients are governed by contracts that provide for overall custody and access to deposited funds and other related services and can be terminated at will by either party. Fees received from deposit clients for the various deposit activities are recognized as revenue by the Company once the performance obligations are met.

<u>Wealth Management Fees</u>

The Company employs financial consultants to provide investment planning services for clients including wealth management services, asset allocation strategies, portfolio analysis and monitoring, investment strategies, and risk management strategies. The fees the Company earns are variable and are generally received monthly by the Company. The Company recognizes revenue for the services performed at quarter end based on actual transaction details received from the broker dealer the Company engages.

<u>Practical Expedients and Exemptions</u>

The Company applies the practical expedient in ASC *606*-*10*-*50*-*14* and does *not* disclose the value of unsatisfied performance obligations as the Company's contracts with clients generally have a term that is less than *one* year, are open-ended with a cancellation period that is less than *one* year or allow the Company to recognize revenue in the amount to which the Company has the right to invoice.

In addition, given the short-term nature of the contracts, the Company also applies the practical expedient in ASC *606*-*10*-*32*-*18* and does *not* adjust the consideration from clients for the effects of a significant financing component, if at contract inception the period between when the entity transfers the goods or services and when the client pays for that good or service is *one* year or less.

***<u>*19.* Stock Repurchase Program</u>***

On *February 4, 2026,* the Company completed its *June 2025* stock repurchase program by repurchasing 243,499 shares at an average cost of $51.31 in the *first* quarter of *2026,* for a total of $12.5 million.

On *April 23, 2026,* the Company announced that its Board of Directors adopted a new share repurchase program authorizing the company to repurchase up to $150.0 million of the Company's common stock.

***<u>*20.* Subsequent Events</u>***

The Company has evaluated the effect of events that have occurred subsequent to *March 31, 2026*, through the date of issuance of the Consolidated Financial Statements, and, other than the realized loss on certain of its AFS debt securities disclosed in Note *5* and the share repurchase program disclosed on Note *19,* the Company believes that there have been *no* material events during such period that would require recognition in the Consolidated Financial Statements or disclosure in the Notes to the Consolidated Financial Statements.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; *24*

------

[**Table of Contents**](#toc)

**Item 2. MANAGEMENT**'**S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.**

The following discussion and analysis should be read in conjunction with the Company's Annual Report on Form 10-K for the year ended December 31, 2025 and are based upon its unaudited Consolidated Financial Statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America. The preparation of these Consolidated Financial Statements requires management to make estimates and judgments that affect the reported amounts of assets and liabilities, revenues, and expenses, and related disclosures of contingent assets and liabilities at the date of the Consolidated Financial Statements. Actual results may differ from these estimates under different assumptions or conditions.

**Highlights**

● Net interest margin increased to 3.43% during the first quarter from 3.25% in the first quarter of 2025.

● Total loans, excluding loans held for sale, increased to $20.17 billion or 0.1%, from $20.15 billion at December 31, 2025.

● Total deposits decreased $218.5 million or 1.0%, to $20.68 billion from December 31, 2025.

***<u>Quarterly Statement of Operations Review</u>***

**Financial Performance**

---

| | | |
|:---|:---|:---|
|  | **Three months ended** | **Three months ended** |
|  | **March 31, 2026** | **March 31, 2025** |
|  | ($ In millions, except per share and ratio data) | ($ In millions, except per share and ratio data) |
| Net income | $86.9 | $69.5 |
| Basic earnings per common share | $1.30 | $0.99 |
| Diluted earnings per common share | $1.29 | $0.98 |
| Return on average assets | 1.47% | 1.22% |
| Return on average total stockholders' equity | 11.88% | 9.84% |
| Efficiency ratio | 40.35% | 45.60% |

---

**Net Interest Income Before Provision for Credit Losses**

Net interest income before provision for credit losses increased $17.6 million, or 10.0%, to $194.2 million during the first quarter of 2026, compared to $176.6 million during the same quarter a year ago. The increase was due primarily to a decrease in interest expense from deposits, offset by a small decrease in interest in deposits with other banks.

The net interest margin was 3.43% for the first quarter of 2026 compared to 3.25% for the first quarter of 2025.

For the first quarter of 2026, the yield on average interest-earning assets was 5.70%, the cost of funds on average interest-bearing liabilities was 2.99%, and the average cost of interest-bearing deposits was 2.96%. In comparison, for the first quarter of 2025, the yield on average interest-earning assets was 5.89%, the cost of funds on average interest-bearing liabilities was 3.46%, and the average cost of interest-bearing deposits was 3.43%. The decrease in the yield on average interest-bearing liabilities and on average interest-earning assets resulted mainly from lower interest rates on deposits and lower interest rates on loans and securities, respectively. The net interest spread, defined as the difference between the yield on average interest-earning assets and the cost of funds on average interest-bearing liabilities, was 2.71% for the quarter ended March 31, 2026, compared to 2.43% for the same quarter a year ago.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 25

------

[**Table of Contents**](#toc)

The following table sets forth information concerning average interest-earning assets, average interest-bearing liabilities, and the average yields and rates paid on those assets and liabilities for the three months ended March 31, 2026, and 2025. The average outstanding amounts included in the table are daily averages.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Interest-Earning Assets and Interest-Bearing Liabilities** | **Interest-Earning Assets and Interest-Bearing Liabilities** | **Interest-Earning Assets and Interest-Bearing Liabilities** | **Interest-Earning Assets and Interest-Bearing Liabilities** | **Interest-Earning Assets and Interest-Bearing Liabilities** | **Interest-Earning Assets and Interest-Bearing Liabilities** |
|  | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
|  | **2026** | **2026** | **2026** | **2025** | **2025** | **2025** |
|  |  | **Interest** | **Average** |  | **Interest** | **Average** |
|  | **Average** | **Income/** | **Yield/** | **Average** | **Income/** | **Yield/** |
|  | **Balance** | **Expense** | **Rate <sup>(1)(2)</sup>** | **Balance** | **Expense** | **Rate <sup>(1)(2)</sup>** |
|  | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) |
| **Interest-earning assets:** |  |  |  |  |  |  |
| Total loans <sup>(1)</sup> | $20162693 | $298935 | 6.01% | $19332602 | $293984 | 6.17% |
| Investment securities | 1670915 | 12983 | 3.15 | 1457724 | 12103 | 3.37 |
| Federal Home Loan Bank stock | 17250 | 874 | 20.56 | 17250 | 379 | 8.92 |
| Deposits with banks | 1128168 | 10118 | 3.64 | 1202304 | 12929 | 4.36 |
| Total interest-earning assets | 22979026 | 322910 | 5.70 | 22009880 | 319395 | 5.89 |
| **Non-interest earning assets:** |  |  |  |  |  |  |
| Cash and due from banks | 155320 |  |  | 177081 |  |  |
| Other non-earning assets | 1118461 |  |  | 1173911 |  |  |
| Total non-interest earning assets | 1273781 |  |  | 1350992 |  |  |
| Less: Allowance for loan losses | (198009) |  |  | (161781) |  |  |
| Deferred loan fees | (14694) |  |  | (11213) |  |  |
| **Total assets** | $**24040104** |  |  | $**23187878** |  |  |
| **Interest-bearing liabilities:** |  |  |  |  |  |  |
| Interest-bearing demand accounts | $2341354 | $8245 | 1.42% | $2142241 | $8863 | 1.68% |
| Money market accounts | 3670457 | 27132 | 3.00 | 3382292 | 28591 | 3.43 |
| Savings accounts | 1514128 | 5629 | 1.51 | 1289628 | 4980 | 1.57 |
| Time deposits | 9688896 | 84846 | 3.55 | 9582826 | 96066 | 4.07 |
| Total interest-bearing deposits | 17214835 | 125852 | 2.96 | 16396987 | 138500 | 3.43 |
| Other borrowings | 128265 | 1061 | 3.35 | 215021 | 2236 | 4.22 |
| Long-term debt | 119136 | 1829 | 6.23 | 119136 | 2020 | 6.88 |
| Total interest-bearing liabilities | 17462236 | 128742 | 2.99 | 16731144 | 142756 | 3.46 |
| **Non-interest bearing liabilities:** |  |  |  |  |  |  |
| Demand deposits | 3352409 |  |  | 3305149 |  |  |
| Other liabilities | 260088 |  |  | 286876 |  |  |
| Total equity | 2965371 |  |  | 2864709 |  |  |
| **Total liabilities and equity** | $**24040104** |  |  | $**23187878** |  |  |
| Net interest spread |  |  | 2.71% |  |  | 2.43% |
| Net interest income |  | $194168 |  |  | $176639 |  |
| Net interest margin |  |  | 3.43% |  |  | 3.25% |
| <sup>(1)</sup> Yields and amounts of interest earned include loan fees. Non-accrual loans are included in the average balance. | <sup>(1)</sup> Yields and amounts of interest earned include loan fees. Non-accrual loans are included in the average balance. | <sup>(1)</sup> Yields and amounts of interest earned include loan fees. Non-accrual loans are included in the average balance. | <sup>(1)</sup> Yields and amounts of interest earned include loan fees. Non-accrual loans are included in the average balance. | <sup>(1)</sup> Yields and amounts of interest earned include loan fees. Non-accrual loans are included in the average balance. | <sup>(1)</sup> Yields and amounts of interest earned include loan fees. Non-accrual loans are included in the average balance. | <sup>(1)</sup> Yields and amounts of interest earned include loan fees. Non-accrual loans are included in the average balance. |
| <sup>(2)</sup> Calculated by dividing net interest income by average outstanding interest-earning assets. | <sup>(2)</sup> Calculated by dividing net interest income by average outstanding interest-earning assets. | <sup>(2)</sup> Calculated by dividing net interest income by average outstanding interest-earning assets. | <sup>(2)</sup> Calculated by dividing net interest income by average outstanding interest-earning assets. | <sup>(2)</sup> Calculated by dividing net interest income by average outstanding interest-earning assets. | <sup>(2)</sup> Calculated by dividing net interest income by average outstanding interest-earning assets. | <sup>(2)</sup> Calculated by dividing net interest income by average outstanding interest-earning assets. |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 26

------

[**Table of Contents**](#toc)

The following table summarizes the changes in interest income and interest expense attributable to changes in volume and changes in interest rates for the three months ended March 31, 2026 and 2025:

---

| | | | |
|:---|:---|:---|:---|
| **Taxable-Equivalent Net Interest Income — Changes Due to Volume and Rate<sup>(1)</sup>** | **Taxable-Equivalent Net Interest Income — Changes Due to Volume and Rate<sup>(1)</sup>** | **Taxable-Equivalent Net Interest Income — Changes Due to Volume and Rate<sup>(1)</sup>** | **Taxable-Equivalent Net Interest Income — Changes Due to Volume and Rate<sup>(1)</sup>** |
|  | **Three Months Ended March 31,** | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
|  | **2026-2025** | **2026-2025** | **2026-2025** |
|  | **Increase/(Decrease) in** | **Increase/(Decrease) in** | **Increase/(Decrease) in** |
|  | **Net Interest Income Due to** | **Net Interest Income Due to** | **Net Interest Income Due to** |
|  | **Changes in Volume** | **Changes in Rate** | **Total Change** |
|  | ($ In thousands) | ($ In thousands) | ($ In thousands) |
| **Interest-earning assets:** |  |  |  |
| Loans | $12553 | $(7602) | $4951 |
| Investment securities | 1706 | (826) | 880 |
| Federal Home Loan Bank stock |  | 495 | 495 |
| Deposits with other banks | (762) | (2049) | (2811) |
| Total changes in interest income | 13497 | (9982) | 3515 |
| **Interest-bearing liabilities:** |  |  |  |
| Interest-bearing demand accounts | 791 | (1409) | (618) |
| Money market accounts | 2353 | (3812) | (1459) |
| Savings accounts | 845 | (196) | 649 |
| Time deposits | 1079 | (12299) | (11220) |
| Other borrowed funds | (779) | (396) | (1175) |
| Long-term debt |  | (191) | (191) |
| Total changes in interest expense | 4289 | (18303) | (14014) |
| **Changes in net interest income** | $9208 | $8321 | $17529 |
| <sup>(1)</sup> Changes in interest income and interest expense attributable to changes in both volume and rate have been allocated proportionately to changes due to volume and changes due to rate. | <sup>(1)</sup> Changes in interest income and interest expense attributable to changes in both volume and rate have been allocated proportionately to changes due to volume and changes due to rate. | <sup>(1)</sup> Changes in interest income and interest expense attributable to changes in both volume and rate have been allocated proportionately to changes due to volume and changes due to rate. | <sup>(1)</sup> Changes in interest income and interest expense attributable to changes in both volume and rate have been allocated proportionately to changes due to volume and changes due to rate. |

---

**Provision for credit losses**

The Company recorded a provision for credit losses of $18.2 million in the first quarter of 2026 compared with $15.5 million in the first quarter of 2025. As of March 31, 2026, the allowance for loan losses, increased $12.9 million to $208.9 million, or 1.03% of total loans, compared to $195.9 million, or 0.97% of total loans as of December 31, 2025.

The following table sets forth the charge-offs and recoveries for the periods indicated:

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
|  | **2026** | **2025** |
|  | ($ In thousands) | ($ In thousands) |
| **Charge-offs:** |  |  |
| Commercial loans | $7971 | $2344 |
| Real estate loans <sup>(1)</sup> | 1385 |  |
| **Total charge-offs** | 9356 | 2344 |
| **Recoveries:** |  |  |
| Commercial loans | 4931 | 270 |
| Real estate loans <sup>(1)</sup> | 2302 | 97 |
| **Total recoveries** | 7233 | 367 |
| **Net charge-offs** | $**2123** | $**1977** |
| <sup>(1)</sup> Real estate loans include commercial real estate loans, residential mortgage loans, and equity lines. | <sup>(1)</sup> Real estate loans include commercial real estate loans, residential mortgage loans, and equity lines. | <sup>(1)</sup> Real estate loans include commercial real estate loans, residential mortgage loans, and equity lines. |

---

**Non-Interest Income**

Non-interest income, which includes revenues from depository service fees, letters of credit commissions, securities gains (losses), wealth management fees, and other sources of fee income, was $20.7 million for the first quarter of 2026, an increase of $9.5 million, or 84.8%, compared to $11.2 million for the first quarter of 2025. The increase was primarily due to an equity securities gain of $17.3 million in first quarter of 2026 compared to a loss of $4.2 million in the first quarter of 2025 for a net increase of $21.5 million gain from equity securities and an increase of $1.1 million in derivative fees, offset by an impairment loss of $15.7 million on available-for-sale investment securities in connection with the Company's decision to sell certain impaired securities within that portfolio when compared to the same quarter a year ago.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 27

------

[**Table of Contents**](#toc)

**Non-Interest Expense**

Non-interest expense increased $1.0 million, or 1.2%, to $86.7 million in the first quarter of 2026 compared to $85.7 million in the same quarter a year ago. The increase in non-interest expense in the first quarter of 2026 was primarily due to an increase of $3.1 million in salaries and employee benefits, an increase of $1.3 million in other real estate owned expense, offset by a decrease of $2.3 million in amortization expense of investments in low-income housing and alternative energy partnerships, and $1.0 million in FDIC and State assessments when compared to the same quarter a year ago. The efficiency ratio was 40.35% in the first quarter of 2026 compared to 45.60% for the same quarter a year ago.

**Income Taxes**

The effective tax rate for the first quarter of 2026 was 21.0% compared to 19.8% for the first quarter of 2025. The effective tax rate includes the impact of low-income housing tax credits in 2025.

***<u>Balance Sheet Review</u>***

**Assets**

Total assets were $24.05 billion as of March 31, 2026, a decrease of $180.9 million, or 0.7%, from $24.23 billion as of December 31, 2025.

**Securities Available-for-Sale**

The carrying value of our securities available-for-sale ("AFS") portfolio was $1.68 billion and $1.66 billion as of March 31, 2026 and December 31, 2025, respectively. The increase in the AFS securities portfolio consists primarily of a net addition of $87.8 million in treasury securities was partially offset by the amortization of existing securities during the three months ended March 31, 2026. The increase was partially offset by the amortization of existing securities. AFS securities represented 7.0% of total assets as of March 31, 2026, compared to 6.8% of total assets as of December 31, 2025.

The portfolio continues to be concentrated in U.S. government-backed securities, with more than 90% of the AFS investment portfolio invested in U.S. Treasuries and agency mortgage-backed securities issued by Fannie Mae and Freddie Mac with the remainder held in investment-grade securities. There was no allowance for credit losses provided against the AFS investment securities as of both March 31, 2026 and December 31, 2025. Additionally, there were no credit losses recognized in earnings during the three months ended March 31, 2026, and December 31, 2025.

The Company actively manages the investment portfolio in the context of asset/liability objectives, interest rate risk, and market conditions. These evaluations may result in changes to portfolio size, composition, or hedging strategies, including adjustments to the mix of securities classified as AFS.

During the quarter, the Company recorded a $15.7 million impairment loss related to its decision to sell certain AFS investment securities as part of a portfolio repositioning initiative designed to improve yield while maintaining the portfolio's overall duration and credit quality. These securities, with a book value of $210.6 million, were subsequently sold in April 2026, resulting in a realized loss of $15.7 million. The AFS portfolio had an effective duration of 1.9 years at March 31, 2026, compared with 2.0 years at December 31, 2025.

**Loans**

Gross loans held for investment were $20.17 billion at March 31, 2026, an increase of $27.4 million, or 0.1%, from $20.15 billion at December 31, 2025. The increase was primarily due to an increase of $98.0 million, or 3.1%, in commercial loans, an increase of $24.0 million, or 0.2%, in commercial real estate loans, and an increase of $6.7 million, or 3.0% in equity lines, offset by a decrease of $53.6 million, or 0.9% in residential mortgage loans, and a decrease of $48.5 million, or 14.4% in real estate construction loans.

The loan held for investment balances and composition at March 31, 2026, compared to December 31, 2025, are set forth below:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **March 31, 2026** | **% of Gross Loans** | **December 31, 2025** | **% of Gross Loans** | **% Change** |
|  | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) |
| Commercial loans | $3282557 | 16.3% | $3184556 | 15.8% | 3.1% |
| Construction loans | 289042 | 1.4 | 337550 | 1.7 | (14.4) |
| Commercial real estate loans | 10588726 | 52.5 | 10564744 | 52.4 | 0.2 |
| Residential mortgage loans and equity lines | 6011671 | 29.8 | 6058538 | 30.1 | (0.8) |
| Installment and other loans | 2593 |  | 1814 |  | 42.9 |
| Gross loans held for investment | $20174589 | 100% | $20147202 | 100% | 0.1% |
| Allowance for loan losses | (208786) |  | (195911) |  | 6.6 |
| Unamortized deferred loan fees | (14164) |  | (14903) |  | (5.0) |
| **Total loans held for investment, net** | $**19951639** |  | $**19936388** |  | **0.1%** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 28

------

[**Table of Contents**](#toc)

**Non-performing Assets**

Non-performing assets include loans past due 90 days or more and still accruing interest, non-accrual loans, and OREO. Our policy is to place loans on non-accrual status if interest and/or principal is past due 90 days or more, or in cases where management deems the full collection of principal and interest unlikely. After a loan is placed on non-accrual status, any previously accrued but unpaid interest is reversed and charged against current income and subsequent payments received are generally first applied towards the outstanding principal balance of the loan. Depending on the circumstances, management may elect to continue the accrual of interest on certain past due loans if partial payment is received and/or the loan is well collateralized and in the process of collection. The loan is generally returned to accrual status when the borrower has brought the past due principal and interest payments current and, in the opinion of management, the borrower has demonstrated the ability to make future payments of principal and interest as scheduled.

Management reviews the loan portfolio regularly to seek to identify problem loans. During the ordinary course of business, management may become aware of borrowers that may not be able to meet the contractual requirements of their loan agreements. Such loans generally are placed under closer supervision with consideration given to placing the loans on non-accrual status, the need for an additional allowance for loan losses, and (if appropriate) partial or full charge-off.

The ratio of non-performing assets to total assets was 0.53% as of March 31, 2026, compared to 0.59% as of December 31, 2025. Total non-performing assets decreased $15.8 million, or 11.0% to $127.9 million at March 31, 2026, compared to $143.7 million at December 31, 2025, primarily due to a decrease of $23.4 million, or 20.8%, in non-accrual loans, offset by, an increase of $4.5 million, or 449.1%, in accruing loans past due 90 days or more, and an increase of $3.1 million, or 10.2%, in other real estate owned.

As a percentage of gross loans, excluding loans held for sale, plus OREO, our non-performing assets were 0.63% and 0.71% as of March 31, 2026, and December 31, 2025, respectively. The non-performing loan portfolio coverage ratio, defined as the allowance for credit losses to non-performing loans, increased to 237.50% as of March 31, 2026, from 183.79% as of December 31, 2025.

The following table sets forth the changes in non-performing assets as of March 31, 2026, compared to December 31, 2025, and to March 31, 2025:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **March 31, 2026** | **December 31, 2025** | **% Change** | **March 31, 2025** | **% Change** |
|  | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) |
| **Non-performing assets** |  |  |  |  |  |
| Accruing loans past due 90 days or more | $5491 | $1000 | 449 | $595 | 823 |
| Non-accrual loans: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Commercial real estate loans | 51091 | 59511 | (14) | 76802 | (33) |
| &nbsp;&nbsp;&nbsp; Commercial loans | 7665 | 21498 | (64) | 53362 | (86) |
| &nbsp;&nbsp;&nbsp; Residential mortgage loans | 30248 | 31354 | (4) | 24462 | 24 |
| Total non-accrual loans | $89004 | $112363 | (21) | $154626 | (42) |
| &nbsp;&nbsp;&nbsp; Total non-performing loans | 94495 | 113363 | (17) | 155221 | (39) |
| Other real estate owned | 33436 | 30336 | 10 | 18484 | 81 |
| &nbsp;&nbsp;&nbsp; Total non-performing assets | $127931 | $143699 | (11) | $173705 | (26) |
| Accruing loan modifications to borrowers experiencing financial difficulties | $84332 | $78148 |  | $8213 |  |
| Non-accrual loans held for sale | $— | $— |  | $11759 |  |
| Allowance for loan losses | $208786 | $195911 | 7 | $173936 | 20 |
| Allowance for unfunded loan commitments | $15636 | $12441 | 26 | $11028 | 42 |
| Total gross loans outstanding, excluding loans held for sale, at period-end | $20174589 | $20147202 | 0 | $19353003 | 4 |
| Allowance for loan losses to non-performing loans, at period-end | 220.95% | 172.82% |  | 112.06% |  |
| Allowance for credit losses to non-performing loans, at period-end | 237.50% | 183.79% |  | 119.16% |  |
| Allowance for loan losses to gross loans, excluding loans held for sale, at period-end | 1.03% | 0.97% |  | 0.90% |  |

---

**Non-accrual Loans**

As of March 31, 2026, total non-accrual loans were $89.0 million, a decrease of $23.4 million, or 20.8%, from $112.4 million at December 31, 2025, and a decrease of $65.6 million, or 42.4%, from $154.6 million at March 31, 2025. The allowance for the collateral-dependent loans is calculated based on the difference between the outstanding loan balance and the value of the collateral as determined by recent appraisals, sales contracts, or other available market price information, less cost to sell. The allowance for collateral-dependent loans varies from loan to loan based on the collateral coverage of the loan at the time of designation as non-performing. We continue to monitor the collateral coverage of these loans, based on recent appraisals, on a quarterly basis and adjust the allowance accordingly.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 29

------

[**Table of Contents**](#toc)

The following tables set forth the type of properties securing the non-accrual portfolio loans and the type of businesses the borrowers engaged in as of the dates indicated:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **March 31, 2026** | **March 31, 2026** | **December 31, 2025** | **December 31, 2025** |
|  | **Real** |  | **Real** |  |
|  | **Estate <sup>(1)</sup>** | **Commercial** | **Estate <sup>(1)</sup>** | **Commercial** |
|  | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) |
| **Type of Collateral** |  |  |  |  |
| Single/multi-family residence | $53935 | $515 | $57676 | $516 |
| Commercial real estate | 27404 | 4782 | 33189 | 3514 |
| Personal property (UCC) |  | 2368 |  | 17468 |
| **Total** | $**81339** | $**7665** | $**90865** | $**21498** |
| <sup>(1)</sup> Real estate includes commercial real estate loans, construction loans, residential mortgage loans, equity lines and installment & other loans. | <sup>(1)</sup> Real estate includes commercial real estate loans, construction loans, residential mortgage loans, equity lines and installment & other loans. | <sup>(1)</sup> Real estate includes commercial real estate loans, construction loans, residential mortgage loans, equity lines and installment & other loans. | <sup>(1)</sup> Real estate includes commercial real estate loans, construction loans, residential mortgage loans, equity lines and installment & other loans. | <sup>(1)</sup> Real estate includes commercial real estate loans, construction loans, residential mortgage loans, equity lines and installment & other loans. |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **March 31, 2026** | **March 31, 2026** | **December 31, 2025** | **December 31, 2025** |
|  | **Real** |  | **Real** |  |
|  | **Estate <sup>(1)</sup>** | **Commercial** | **Estate <sup>(1)</sup>** | **Commercial** |
|  | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) |
| **Type of Business** |  |  |  |  |
| Real estate development | $33248 | $— | $40848 | $4873 |
| Wholesale/Retail | 17843 | 5862 | 18662 | 15812 |
| Food/Restaurant |  | 1327 | 42 | 40 |
| Import/Export |  | 476 |  | 476 |
| Other | 30248 |  | 31313 | 297 |
| **Total** | $**81339** | $**7665** | $**90865** | $**21498** |
| <sup>(1)</sup> Real estate includes commercial real estate loans, construction loans, residential mortgage loans, equity lines and installment & other loans. | <sup>(1)</sup> Real estate includes commercial real estate loans, construction loans, residential mortgage loans, equity lines and installment & other loans. | <sup>(1)</sup> Real estate includes commercial real estate loans, construction loans, residential mortgage loans, equity lines and installment & other loans. | <sup>(1)</sup> Real estate includes commercial real estate loans, construction loans, residential mortgage loans, equity lines and installment & other loans. | <sup>(1)</sup> Real estate includes commercial real estate loans, construction loans, residential mortgage loans, equity lines and installment & other loans. |

---

For non-accrual loans, the amounts previously charged-off represent 7.7% of the contractual balances for non-accrual loans as of March 31, 2026, and 14.4% as of December 31, 2025. As of March 31, 2026, $81.3 million, or 91.4%, of the $89.0 million of non-accrual loans were secured by real estate compared to $90.9 million, or 80.8%, of the $112.4 million of non-accrual loans that were secured by real estate as of December 31, 2025. The Bank generally seeks to obtain current appraisals, sales contracts, or other available market price information intended to provide updated factors in evaluating potential loss.

The allowance for loan losses to non-performing loans was 220.95% as of March 31, 2026, compared to 172.82% as of December 31, 2025. The increase was due primarily to a net increase in the allowance for loan losses and a decrease in non-accrual loans.

**Loan Interest Reserves**

In accordance with customary banking practice, construction loans and land development loans generally are originated where interest on the loan is disbursed from pre-established interest reserves included in the total original loan commitment. Our construction loans and land development loans generally include optional renewal terms after the maturity of the initial loan term. New appraisals are obtained prior to extension or renewal of these loans in part to determine the appropriate interest reserve to be established for the new loan term. Loans with interest reserves are generally underwritten to the same criteria, including loan to value and, if applicable, pro forma debt service coverage ratios, as loans without interest reserves. Construction loans with interest reserves are monitored on a periodic basis to gauge progress towards completion. Interest reserves are frozen if it is determined that additional draws would result in a loan to value ratio that exceeds policy maximums based on collateral property type. Our policy limits in this regard are consistent with supervisory limits and range from 50% in the case of land to 85% in the case of one to four family residential construction projects.

As of March 31, 2026, construction loans of $197.1 million were disbursed with pre-established interest reserves of $29.1 million, compared to $225.9 million with pre-established interest reserves of $34.0 million at December 31, 2025. There were no balances on construction loans with interest reserves that have been extended with pre-established interest reserves of $380 thousand at March 31, 2026, compared to a balance of $3.3 million with pre-established interest reserves of $95 thousand at December 31, 2025. Land loans of $18.1 million were disbursed with pre-established interest reserves of $1.5 million at March 31, 2026, compared to land loans of $15.3 million with pre-established interest reserves of $1.3 million at December 31, 2025. There were no land loans with interest reserves which have been extended as of March 31, 2026, and December 31, 2025.

At March 31, 2026, and December 31, 2025, the Bank had no loan on non-accrual status with available interest reserves. There were no non-accrual residential construction loans, non-accrual non-residential construction loans, and non-accrual land loans that were originated with pre-established interest reserves as of March 31, 2026, and December 31, 2025. While we typically expect loans with interest reserves to be repaid in full according to the original contractual terms, some loans may require one or more extensions beyond the original maturity before full repayment. Typically, these extensions are required due to construction delays, delays in the sale or lease of the property, or some combination of these two factors.

**Loan Concentration**

Most of the Company's business activities are with clients located in the high-density Asian-populated areas of Southern and Northern California; New York City, New York; Dallas and Houston, Texas; Seattle, Washington; Boston, Massachusetts; Chicago, Illinois; Edison, New Jersey; Rockville, Maryland; and Las Vegas, Nevada. The Company also has loan clients in Hong Kong. The Company has no significant industry concentration, and generally our loans are collateralized with real property or other pledged collateral of the borrowers. The Company generally expects loans to be paid off from the operating profits of the borrowers, refinancing by another lender, or through sale by the borrowers of the collateral.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 30

------

[**Table of Contents**](#toc)

The federal banking regulatory agencies issued final guidance on December 6, 2006, regarding risk management practices for financial institutions with high or increasing concentrations of commercial real estate ("CRE") loans on their balance sheets. The regulatory guidance reiterates the need for sound internal risk management practices for those institutions that have experienced rapid growth in CRE lending, have notable exposure to specific types of CRE, or are approaching or exceeding the supervisory criteria used to evaluate the CRE concentration risk, but the guidance is not to be construed as a limit for CRE exposure. The supervisory criteria are: (1) total reported loans for construction, land development, and other land represent 100% of the institution's total risk-based capital, and (2) both total CRE loans represent 300% or more of the institution's total risk-based capital and the institution's CRE loan portfolio has increased 50% or more within the last thirty-six months. The Bank's loans for construction, land development, and other land represented 12% of the Bank's total risk-based capital as of March 31, 2026, and 14% as of December 31, 2025. Total CRE loans represented 278% of total risk-based capital as of March 31, 2026, and 287% as of December 31, 2025, which were within the Bank's internal limit of 400%, of total capital.

**CRE and Construction Loans ("CREC")**

The Company's total CREC loan portfolio is diversified by property type with an average CREC loan size of $2.0 million as of March 31, 2026, and December 31, 2025. The following table summarizes the Company's total CREC loans by property type as of March 31, 2026, and December 31, 2025:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **As of March 31, 2026** | **As of March 31, 2026** | **As of December 31, 2025** | **As of December 31, 2025** |
| ($ In thousands) | **Amount** | **%** | **Amount** | **%** |
| **Property type:** |  |  |  |  |
| Retail | $2575582 | 24% | $2545446 | 24% |
| Multifamily | 2874037 | 27% | 2887642 | 27% |
| Office | 1398982 | 13% | 1439568 | 13% |
| Warehouse | 1417415 | 13% | 1359887 | 12% |
| Industrial | 695203 | 6% | 692280 | 6% |
| Hospitality | 359436 | 3% | 360692 | 3% |
| Construction & Land | 360726 | 3% | 407957 | 4% |
| Other | 1196385 | 11% | 1208822 | 11% |
| **Total CREC loans** | $**10877766** | **100%** | $**10902294** | **100%** |

---

The weighted-average loan-to-value ("LTV") ratio of the total CREC loan portfolio was 49% as of March 31, 2026, and December 31, 2025. Approximately 86% of total CREC loans had an LTV ratio of 60% or lower as of March 31, 2026, and December 31, 2025.

The following tables provide a summary of the Company's CREC, multifamily residential, and construction and land loans by geography as of March 31, 2026, and December 31, 2025. The distribution of the total CREC loan portfolio reflects the Company's geographical footprint, which is primarily concentrated in California:

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **As of March 31, 2026** | **As of March 31, 2026** | **As of March 31, 2026** | **As of March 31, 2026** | **As of March 31, 2026** | **As of March 31, 2026** | **As of March 31, 2026** | **As of March 31, 2026** |
| ($ In thousands) | **CRE** | **%** | **Multifamily Residential** | **%** | **Construction and Land** | **%** | **Total** | **%** |
| **Geographic markets:** |  |  |  |  |  |  |  |  |
| California | $3639033 | 48% | $1068444 | 37% | $231333 | 64% | $4938810 | 45% |
| New York | 2425187 | 32% | 1333604 | 46% | 77709 | 22% | 3836500 | 35% |
| Texas | 386543 | 5% | 205097 | 7% | 4243 | 1% | 595883 | 6% |
| Illinois | 250784 | 3% | 44554 | 2% | 2736 | 1% | 298074 | 3% |
| New Jersey | 171203 | 2% | 21028 | 1% | 2773 | 1% | 195004 | 2% |
| Nevada | 214470 | 3% | 28374 | 1% | 8267 | 2% | 251111 | 2% |
| Washington | 60083 | 1% | 144442 | 5% | 25335 | 7% | 229860 | 2% |
| Other markets | 495700 | 6% | 28494 | 1% | 8330 | 2% | 532524 | 5% |
| **Total CREC loans** | $**7643003** | **100%** | $**2874037** | **100%** | $**360726** | **100%** | $**10877766** | **100%** |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
|  | **As of December 31, 2025** | **As of December 31, 2025** | **As of December 31, 2025** | **As of December 31, 2025** | **As of December 31, 2025** | **As of December 31, 2025** | **As of December 31, 2025** | **As of December 31, 2025** |
| ($ In thousands) | **CRE** | **%** | **Multifamily Residential** | **%** | **Construction and Land** | **%** | **Total** | **%** |
| **Geographic markets:** |  |  |  |  |  |  |  |  |
| California | $3649273 | 48% | $1130859 | 39% | $272251 | 67% | $5052383 | 46% |
| New York | 2373202 | 31% | 1291064 | 45% | 102685 | 25% | 3766951 | 35% |
| Texas | 388334 | 5% | 202313 | 7% |  | 0% | 590647 | 5% |
| Illinois | 251271 | 3% | 44961 | 1% | 1895 | 1% | 298127 | 3% |
| New Jersey | 170358 | 2% | 19153 | 1% | 1603 | 0% | 191114 | 2% |
| Nevada | 209928 | 3% | 27523 | 1% | 5259 | 1% | 242710 | 2% |
| Washington | 66130 | 1% | 143135 | 5% | 15934 | 4% | 225199 | 2% |
| Other markets | 498199 | 7% | 28634 | 1% | 8330 | 2% | 535163 | 5% |
| **Total CREC loans** | $**7606695** | **100%** | $**2887642** | **100%** | $**407957** | **100%** | $**10902294** | **100%** |

---

There were 45% and 46% of total CREC loans concentrated in California as of March 31, 2026, and December 31, 2025, respectively. Changes in California's economy and real estate values could have a significant impact on the collectability of these loans and the required level of allowance for loan losses.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 31

------

[**Table of Contents**](#toc)

**Commercial Real Estate Loans**

The Company focuses on providing financing to experienced real estate investors and developers who have moderate levels of leverage, many of whom are long-time customers of the Bank. CRE loans totaled $7.64 billion as of March 31, 2026, compared with $7.61 billion as of December 31, 2025, and accounted for 38% of total loans held-for-investment, not including loans held for sale, as of March 31, 2026, and December 31, 2025. Interest rates on CRE loans may be fixed or variable. As of March 31, 2026, 21% and 40% of our CRE portfolio were variable rate and hybrid loans in their fixed period, respectively. In comparison, as of December 31, 2025, 21% and 40% of our CRE portfolio were variable rate and hybrid loans in their fixed period, respectively. Loans are underwritten with conservative standards for cash flows, debt service coverage and LTV.

Owner-occupied properties comprised 25% of the CRE loans as of March 31, 2026, and December 31, 2025. The remainder were non-owner-occupied properties, where 50% or more of the debt service for the loan is typically provided by rental income from an unaffiliated third party.

**Commercial-Multifamily Residential Loans**

The multifamily residential loan portfolio is largely comprised of loans secured by residential properties with five or more units. Multifamily residential loans totaled $2.87 billion as of March 31, 2026, compared with $2.89 billion as of December 31, 2025, and accounted for 14% of total loans held-for investment, not including loans held for sale, as of March 31, 2026, and December 31, 2025. The Company offers a variety of first lien mortgages, including fixed and variable-rate loans. As of March 31, 2026, 22% and 40% of our multifamily residential loan portfolio were variable rate and hybrid loans in their fixed period, respectively. In comparison, as of December 31, 2025, 24% and 36% of our multifamily residential loan portfolio were variable rate and hybrid loans in their fixed period, respectively.

**Commercial-Construction and Land Loans**

Construction and land loans provide financing for diversified projects by real estate property type. Construction and land loans totaled $360.7 million as of March 31, 2026, compared with $408.0 million as of December 31, 2025, and accounted for 2% of total loans held-for-investment, not including loans held for sale, as of March 31, 2026, and December 31, 2025. Construction loan exposure was made up of $289.0 million in outstanding loans, plus $199.8 million in unfunded commitments as of March 31, 2026, compared with $337.6 million in outstanding loans, plus $235.3 million in unfunded commitments as of December 31, 2025. Land loans totaled $71.7 million as of March 31, 2026, compared with $70.4 million as of December 31, 2025.

**Allowance for Credit Losses**

The following table sets forth information relating to the allowance for loan losses, charge-offs, recoveries, and the reserve for off-balance sheet credit commitments for the periods indicated:

---

| | | |
|:---|:---|:---|
|  | **Three Months Ended March 31,** | **Three Months Ended March 31,** |
|  | **2026** | **2025** |
|  | ($ In thousands) | ($ In thousands) |
| **Allowance for loan losses** |  |  |
| Balance at beginning of period | $195911 | $161765 |
| Provision for expected credit losses on loans | 14998 | 14148 |
| **Charge-offs:** |  |  |
| Commercial loans | (7971) | (2344) |
| Real estate loans <sup>(1)</sup> | (1385) |  |
| **Total charge-offs** | (9356) | (2344) |
| **Recoveries:** |  |  |
| Commercial loans | 4931 | 270 |
| Real estate loans <sup>(1)</sup> | 2302 | 97 |
| **Total recoveries** | 7233 | 367 |
| **Balance at the end of period** | $**208786** | $**173936** |
| **Reserve for off-balance sheet credit commitments** |  |  |
| Balance at beginning of period | $12441 | $9676 |
| Provision for expected credit losses on unfunded credit commitments | 3195 | 1352 |
| **Balance at the end of period** | $**15636** | $**11028** |
| Average loans outstanding during the period | $20162693 | $19332602 |
| Total gross loans outstanding, excluding loans held for sale, at period-end | $20174589 | $19353003 |
| Total non-performing loans, at period-end | $94495 | $155221 |
| Ratio of net charge-offs to average loans outstanding during the period<sup>(2)</sup> | 0.04% | 0.04% |
| Provision for expected credit losses to average loans outstanding during the period<sup>(2)</sup> | 0.37% | 0.33% |
| Allowance for loan losses to non-performing loans, at period-end | 220.95% | 112.06% |
| Allowance for loan losses to gross loans, excluding loans held for sale, at period-end | 1.03% | 0.90% |
| <sup>(1)</sup> Real estate loans include commercial real estate loans, residential mortgage loans, and equity lines. | <sup>(1)</sup> Real estate loans include commercial real estate loans, residential mortgage loans, and equity lines. | <sup>(1)</sup> Real estate loans include commercial real estate loans, residential mortgage loans, and equity lines. |
| <sup>(2)</sup> Annualized. | <sup>(2)</sup> Annualized. | <sup>(2)</sup> Annualized. |

---

 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 32

------

[**Table of Contents**](#toc)

The table set forth below reflects management's allocation of the allowance for loan losses by loan category and the ratio of each loan category to the average gross loans as of the dates indicated:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **March 31, 2026** | **March 31, 2026** | **December 31, 2025** | **December 31, 2025** |
|  |  | **Percentage of** |  | **Percentage of** |
|  |  | **Loans in Each** |  | **Loans in Each** |
|  |  | **Category** |  | **Category** |
|  |  | **to Average** |  | **to Average** |
|  | **Amount** | **Gross Loans** | **Amount** | **Gross Loans** |
|  | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) |
| **Type of Loan:** |  |  |  |  |
| Commercial loans | $46720 | 16.3% | $39123 | 15.9% |
| Construction loans | 15404 | 1.6 | 6475 | 1.7 |
| Commercial real estate loans | 122332 | 52.3 | 125665 | 52.3 |
| Residential mortgage loans and equity lines | 24314 | 29.8 | 24641 | 30.1 |
| Installment and other loans | 16 | 0.0 | 7 | 0.0 |
| **Total allowance** | $**208786** | **100%** | $**195911** | **100%** |

---

The increase in the ACL during the quarter was driven primarily by changes in the quantitative component of the reserve. Quantitative reserves increased due to higher modeled lifetime loss estimates, reflecting updates to certain model assumptions intended to better capture the portfolio's historical loss experience across economic cycles. These updates resulted in higher expected credit losses across several loan categories.

The qualitative component of the allowance was relatively stable in total; however, qualitative adjustments shifted across portfolios based on management's assessment of credit conditions and risk trends. In particular, additional qualitative reserves were applied to certain commercial real estate segments, including office and construction, to reflect market-specific considerations not fully captured in the model's baseline economic forecasts. These increases were offset by reductions in qualitative reserves in other portfolios, resulting in an overall qualitative reserve level that was broadly unchanged from the prior quarter.

The ACL is also influenced by the macroeconomic forecasts used in the Company's CECL model. The March 31, 2026 estimate incorporated multiple forward-looking economic scenarios obtained from a reputable third-party forecaster. These scenarios reflect a range of potential economic outcomes and include a baseline view of expected conditions, along with more optimistic and more adverse alternatives. Management applies judgment in determining how these scenarios are incorporated into the allowance estimate, taking into account prevailing economic uncertainty and risks.

To illustrate the sensitivity of the allowance to changes in economic assumptions, management estimates that applying a 100% weighting to the downside scenario would have increased the ACL by approximately $70.7 million as of March 31, 2026. This analysis is intended to demonstrate the directional impact of more adverse economic conditions and should not be interpreted as a forecast of future allowance levels.

Our methodology, policies and estimates on allowance for credit losses for loans are described in *Item 7 - Management*'*s Discussion and Analysis of Financial Condition and Results of Operations* included in the 2025 Form 10-K. For more information, please also see Note 6 to the Company's unaudited Consolidated Financial Statements.

**Deposits**

Total deposits were $20.68 billion as of March 31, 2026, a decrease of $218.5 million, or 1.0% from $20.89 billion as of December 31, 2025.

The Company calculates its uninsured deposits based on the methodologies and assumptions used for regulatory reporting. Total uninsured deposits were $10.08 billion as of March 31, 2026, decreasing approximately $116.5 million, from $10.19 billion as of December 31, 2025. Excluding $865.3 million in collateralized deposits, the uninsured and uncollateralized deposits of $9.21 billion was 44.6% of total deposits as of March 31, 2026. Our unused borrowing capacity from the Federal Home Loan Bank as of March 31, 2026, was $7.95 billion and unpledged securities at March 31, 2026, was $1.66 billion. These sources of available liquidity, including cash and short-term investments, were more than 100% of uninsured and uncollateralized deposits as of March 31, 2026.

The following table sets forth the deposit mix as of the dates indicated:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **March 31, 2026** | **March 31, 2026** | **December 31, 2025** | **December 31, 2025** |
|  | **Amount** | **Percentage** | **Amount** | **Percentage** |
|  | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) |
| **Deposits** |  |  |  |  |
| Non-interest-bearing demand deposits | $3399461 | 16.5% | $3505606 | 16.8% |
| NOW deposits | 2336121 | 11.3 | 2370047 | 11.3 |
| Money market deposits | 3701873 | 17.9 | 3800471 | 18.2 |
| Savings deposits | 1518300 | 7.3 | 1500890 | 7.2 |
| Time deposits | 9719892 | 47.0 | 9717153 | 46.5 |
| **Total deposits** | $**20675647** | **100.0%** | $**20894167** | **100.0%** |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 33

------

[**Table of Contents**](#toc)

The following table sets forth the maturity distribution of time deposits as of March 31, 2026:

---

| | | | |
|:---|:---|:---|:---|
|  | **As of March 31, 2026** | **As of March 31, 2026** | **As of March 31, 2026** |
|  | **Time Deposits - under $250,000** | **Time Deposits -$250,000 and over** | **Total Time Deposits** |
|  | ($ In thousands) | ($ In thousands) | ($ In thousands) |
| Three months or less | $1255541 | $1977261 | $3232802 |
| Over three to six months | 1480183 | 1710783 | 3190966 |
| Over six to twelve months | 1193527 | 2074261 | 3267788 |
| Over twelve months | 17913 | 10423 | 28336 |
| **Total** | $**3947164** | $**5772728** | $**9719892** |
| Percent of total deposits | 19.1% | 27.9% | 47.0% |

---

**FDIC Special Assessment and Uninsured Deposits**

In 2023, the FDIC issued a final rule implementing a special assessment for certain banks to recover losses to the DIF associated with protecting uninsured depositors of Silicon Valley Bank and Signature Bank upon their failure in March 2023. The Company paid its eighth and final quarterly special assessment during the three months ended March 31, 2026, and its remaining accrual for its estimated special assessment liability is zero as of March 31, 2026. The Company will continue to monitor the estimated loss attributable to the protection of uninsured depositors at Silicon Valley Bank and Signature Bank, which could impact the amount of its accrued liability. In December 2025, the FDIC issued an interim final rule outlining a process for a potential offset to regular quarterly deposit insurance assessments for banks subject to the special assessment if the special assessment amount collected ultimately exceeds losses to the DIF. The FDIC plans to provide additional updates on future offsets or a one-time final shortfall special assessment collection, if any, through future invoices.

**Off-Balance-Sheet Arrangements and Contractual Obligations**

The following table summarizes the Company's contractual obligations to make future payments as of March 31, 2026. Payments for deposits and borrowings do not include interest. Payments related to leases are based on actual payments specified in the underlying contracts:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | **Payment Due by Period** | **Payment Due by Period** | **Payment Due by Period** | **Payment Due by Period** | **Payment Due by Period** |
|  |  | **More than** | **3 years or** |  |  |
|  |  | **1 year but** | **more but** |  |  |
|  | **1 year** | **less than** | **less than** | **5 years** |  |
|  | **or less** | **3 years** | **5 years** | **or more** | **Total** |
|  | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) |
| Contractual obligations: |  |  |  |  |  |
| Deposits with stated maturity dates | $9691556 | $28298 | $38 | $— | $9719892 |
| Other borrowings |  |  |  | 13526 | 13526 |
| Long-term debt |  |  |  | 119136 | 119136 |
| Operating leases | 11133 | 18429 | 8034 | 2469 | 40065 |
| Total contractual obligations and other commitments | $9702689 | $46727 | $8072 | $135131 | $9892619 |

---

In the normal course of business, we enter into various transactions, which, in accordance with GAAP, are not included in our Consolidated Balance Sheets. We enter into these transactions to meet the financing needs of our clients. These transactions include commitments to extend credit and standby letters of credit, which involve, to varying degrees, elements of credit risk and interest rate risk in excess of the amounts recognized in the Consolidated Balance Sheets.

*Loan Commitments* - We enter into contractual commitments to extend credit, normally with fixed expiration dates or termination clauses, at specified rates and for specific purposes. Substantially all of our commitments to extend credit are contingent upon clients maintaining specific credit standards at the time of loan funding. We minimize our exposure to loss under these commitments by subjecting them to credit approval and monitoring procedures. Management assesses the credit risk associated with certain commitments to extend credit in determining the level of the allowance for credit losses.

*Standby Letters of Credit* - Standby letters of credit are written conditional commitments issued by us to secure the obligations of a client to a third party. In the event the client does not perform in accordance with the terms of an agreement with the third party, we would be required to fund the commitment. The maximum potential amount of future payments we could be required to make is represented by the contractual amount of the commitment. If the commitment is funded, we would be entitled to seek reimbursement from the client. Our policies generally require that standby letter of credit arrangements contain security and debt covenants similar to those contained in loan agreements.

***<u>Capital Resources</u>***

Total equity was $2.99 billion as of March 31, 2026, an increase of $61.3 million, from $2.93 billion as of December 31, 2025, primarily due to net income of $86.9 million, other comprehensive income of $10.2 million, stock-based compensation of $1.6 million, and proceeds from dividend reinvestment of $0.7 million, offset by common stock cash dividends of $25.4 million, and purchase of treasury stock of $12.6 million.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 34

------

[**Table of Contents**](#toc)

The following table summarizes changes in total equity for the three months ended March 31, 2026:

---

| | |
|:---|:---|
|  | **Three Months Ended** |
|  | **March 31, 2026** |
|  | ($ In thousands) |
| Net income | $86886 |
| Proceeds from shares issued through the Dividend Reinvestment Plan | 675 |
| Shares withheld related to net share settlement of RSUs | (38) |
| Purchase of treasury stock | (12612) |
| Stock-based compensation | 1571 |
| Cash dividends paid to common stockholders | (25444) |
| Other comprehensive income | 10222 |
| **Net increase in total equity** | $**61260** |

---

***<u>Capital Adequacy Review</u>***

Management seeks to retain our capital at a level sufficient to support future growth, protect depositors and stockholders, and comply with various regulatory requirements.

The following tables set forth actual and required capital ratios as of March 31, 2026, and December 31, 2025, for Bancorp and the Bank under the Basel III Capital Rules. Capital levels required to be considered well capitalized are based upon prompt corrective action regulations, as amended to reflect the changes under the Basel III Capital Rules. See the 2025 Form 10-K for a more detailed discussion of the Basel III Capital Rules.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Actual** | **Actual** | **For Capital Adequacy Purposes** | **For Capital Adequacy Purposes** | **To Be Well-Capitalized Under Prompt Corrective Action provisions** | **To Be Well-Capitalized Under Prompt Corrective Action provisions** |
|  | **Capital Amount** | **Ratio** | **Capital Amount** | **Ratio** | **Capital Amount** | **Ratio** |
|  | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) |
| **March 31, 2026** |  |  |  |  |  |  |
| Cathay General Bancorp: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Common Equity Tier 1 to Risk-Weighted Assets | $2643213 | 13.47 | $883341 | 4.50 |  |  |
| &nbsp;&nbsp;&nbsp; Tier 1 Capital to Risk-Weighted Assets | 2643213 | 13.47 | 1177788 | 6.00 |  |  |
| &nbsp;&nbsp;&nbsp; Total Capital to Risk-Weighted Assets | 2983136 | 15.20 | 1570384 | 8.00 |  |  |
| &nbsp;&nbsp;&nbsp; Leverage Ratio | 2643213 | 11.15 | 948091 | 4.00 |  |  |
| Cathay Bank: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Common Equity Tier 1 to Risk-Weighted Assets | $2728682 | 13.91 | $882927 | 4.50 | $127534 | 6.50 |
| &nbsp;&nbsp;&nbsp; Tier 1 Capital to Risk-Weighted Assets | 2728682 | 13.91 | 1177236 | 6.00 | 1569648 | 8.00 |
| &nbsp;&nbsp;&nbsp; Total Capital to Risk-Weighted Assets | 2953105 | 15.05 | 1569648 | 8.00 | 1962061 | 10.00 |
| &nbsp;&nbsp;&nbsp; Leverage Ratio | 2728682 | 11.52 | 947496 | 4.00 | 1184370 | 5.00 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | **Actual** | **Actual** | **For Capital Adequacy Purposes** | **For Capital Adequacy Purposes** | **To Be Well-Capitalized Under Prompt Corrective Action provisions** | **To Be Well-Capitalized Under Prompt Corrective Action provisions** |
|  | **Capital Amount** | **Ratio** | **Capital Amount** | **Ratio** | **Capital Amount** | **Ratio** |
|  | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) | ($ In thousands) |
| **December 31, 2025** |  |  |  |  |  |  |
| Cathay General Bancorp: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Common Equity Tier 1 to Risk-Weighted Assets | $2590921 | 13.27 | $878810 | 4.50 |  |  |
| &nbsp;&nbsp;&nbsp; Tier 1 Capital to Risk-Weighted Assets | 2590921 | 13.27 | 1171746 | 6.00 |  |  |
| &nbsp;&nbsp;&nbsp; Total Capital to Risk-Weighted Assets | 2914774 | 14.93 | 1562328 | 8.00 |  |  |
| &nbsp;&nbsp;&nbsp; Leverage Ratio | 2590921 | 10.91 | 950270 | 4.00 |  |  |
| Cathay Bank: |  |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Common Equity Tier 1 to Risk-Weighted Assets | $2678692 | 13.73 | $878257 | 4.50 | $1268593 | 6.50 |
| &nbsp;&nbsp;&nbsp; Tier 1 Capital to Risk-Weighted Assets | 2678692 | 13.73 | 1171009 | 6.00 | 1561345 | 8.00 |
| &nbsp;&nbsp;&nbsp; Total Capital to Risk-Weighted Assets | 2887045 | 14.79 | 1561345 | 8.00 | 1951682 | 10.00 |
| &nbsp;&nbsp;&nbsp; Leverage Ratio | 2678692 | 11.28 | 949627 | 4.00 | 1187034 | 5.00 |

---

As of March 31, 2026, capital levels at Bancorp and the Bank exceed all capital adequacy requirements under the fully phased-in Basel III Capital Rules. Based on the ratios presented above, capital levels as of March 31, 2026, at Bancorp and the Bank exceed the minimum levels necessary to be considered "well capitalized."

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 35

------

[**Table of Contents**](#toc)

***<u>Dividend Policy</u>***

Holders of common stock are entitled to dividends as and when declared by our Board of Directors out of funds legally available for the payment of dividends. Although we have historically paid cash dividends on our common stock, we are not required to do so. The Company declared cash dividends per common share of $0.38 and $0.34 for the three months ended March 31, 2026, and 2025, respectively. The amount of future dividends, if any, will depend on our earnings, financial condition, capital requirements and other factors, and will be determined by our Board of Directors. The terms of our Junior Subordinated Notes also limit our ability to pay dividends. If we are not current in our payment of dividends on our Junior Subordinated Notes, we may not pay dividends on our common stock.

The Company declared a cash dividend of $0.38 per share on 66,957,659 shares outstanding on February 26, 2026, for distribution to holders of our common stock on March 9, 2026. The Company paid total cash dividends of $25.4 million in the first quarter of 2026.

***<u>Liquidity</u>***

Liquidity is our ability to maintain sufficient cash flow to meet maturing financial obligations and client credit needs, and to take advantage of investment opportunities as they are presented in the marketplace. Our principal sources of liquidity are growth in deposits, proceeds from the maturity or sale of securities and other financial instruments, repayments from securities and loans, Federal funds purchased, securities sold under agreements to repurchase, and advances from the FHLB. As of March 31, 2026, our average monthly liquidity ratio (defined as net cash plus short-term and marketable securities to net deposits and short-term liabilities) was 13.9% compared to 14.7% as of December 31, 2025.

The Bank is a shareholder of the FHLB, which enables the Bank to have access to lower-cost FHLB financing when necessary. At March 31, 2026, the Bank had an approved credit line with the FHLB of San Francisco totaling $8.47 billion. There were no total advances from the FHLB of San Francisco and there were $959.5 million in standby letters of credit issued by the FHLB on the Company's behalf as of March 31, 2026. These borrowings bear fixed rates and are secured by the Bank's loans. See Note 9 to the Consolidated Financial Statements. At March 31, 2026, the Bank pledged $1.38 billion of its commercial loans and $1.4 million of securities to the Federal Reserve Bank's Discount Window under the Borrower-in-Custody program. The Bank had borrowing capacity of $1.26 billion from the Federal Reserve Bank Discount Window at March 31, 2026.

Liquidity can also be provided through the sale of liquid assets, which may consist of federal funds sold, securities purchased under agreements to resell, and securities available-for-sale. At March 31, 2026, investment securities totaled $1.68 billion, with $22.5 million pledged as collateral for borrowings and other commitments. The remaining balance was available as additional liquidity or to be pledged as collateral for additional borrowings.

Approximately 99.7% of our time deposits mature within one year or less as of March 31, 2026. Management anticipates that these deposits will reprice lower as a result of the expected decreases in the target Fed funds rate expected in 2025. Management anticipates that there may be some outflow of these deposits upon maturity due to the keen competition in the Bank's marketplace. However, based on our historical runoff experience, we expect the outflow will not be significant and can be replenished through our normal growth in deposits. As of March 31, 2026, management believes all the above-mentioned sources will provide adequate liquidity during the next twelve months for the Bank to meet its operating needs.

The business activities of Bancorp consist primarily of the operation of the Bank and limited activities in other investments. The Bank paid dividends to Bancorp totaling $45.0 million and $40.0 million during the first quarter of 2026 and 2025, respectively.

***<u>Critical Accounting Policies</u>***

Our most significant accounting policies are described in Note 1 to the consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2025. Certain of these accounting policies require management to use significant judgment and estimates, which can have a material impact on the carrying value of certain assets and liabilities. We consider these policies to be our critical accounting estimates. The judgment and assumptions made are based upon historical experience, future forecasts, or other factors that management believes to be reasonable under the circumstances. Because of the nature of the judgment and assumptions, actual results could differ from estimates, which could have a material effect on our financial condition and results of operations.

For additional information regarding critical accounting estimates, see the section titled "Critical Accounting Policies" included in Item 7 of our Annual Report on Form 10-K for the year ended December 31, 2025. There have been no material changes in the Company's application of critical accounting estimates since December 31, 2025.

**Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK**

We use a net interest income simulation model to measure the extent of the differences in the behavior of the lending and funding rates to changing interest rates, to project future earnings or market values under alternative interest rate scenarios. Interest rate risk arises primarily through the Company's traditional business activities of extending loans and accepting deposits. Many factors, including but not limited to economic, market and financial conditions, movements in interest rates, and consumer preferences, affect the spread between interest earned on assets and interest paid on liabilities. The net interest income simulation model is designed to measure the volatility of net interest income and net portfolio value, defined as net present value of assets and liabilities, under immediate rising or falling interest rate scenarios in 25 basis points increments.

Although the modeling can be helpful in managing interest rate risk, it does require significant assumptions for the projection of loan prepayment rates on mortgage related assets, loan volumes and pricing, and deposit and borrowing volume and pricing, that might prove inaccurate. Because these assumptions are inherently uncertain, the model cannot precisely estimate net interest income, or precisely predict the effect of higher or lower interest rates on net interest income. Actual results will differ from simulated results due to the timing, magnitude, and frequency of interest rate changes, the differences between actual experience and the assumed volume, changes in market conditions, and management strategies, among other factors. The Company monitors its interest rate sensitivity and seeks to reduce the risk of a significant decrease in net interest income caused by a change in interest rates.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 36

------

[**Table of Contents**](#toc)

We have established a tolerance level in our policy for net interest income volatility when the hypothetical change is plus or down 100 or 200 basis points or more. When the net interest rate simulation projects that our tolerance level will be met or exceeded, we seek corrective action after considering, among other things, market conditions and the estimated impact on profitability. The table below shows the estimated impact of changes in interest rates on net interest income and market value of equity as of March 31, 2026:

---

| | | |
|:---|:---|:---|
|  | Net Interest | Market Value |
|  | Income | of Equity |
| Change in Interest Rate (Basis Points) | Volatility <sup>(1)</sup> | Volatility <sup>(2)</sup> |
| +200 | -3.7 | -27.6 |
| +100 | -1.8 | -14.2 |
| -100 | 3.4 | 15.3 |
| -200 | 6.4 | 30.7 |
| <sup>(1)</sup> The percentage change in this column represents net interest income of the Company for 12 months in a stable interest rate environment versus the net interest income in the various rate scenarios. Much of the increase in net interest income is due to the lag in the repricing of certificates of deposits which mature throughout the twelve month period. | <sup>(1)</sup> The percentage change in this column represents net interest income of the Company for 12 months in a stable interest rate environment versus the net interest income in the various rate scenarios. Much of the increase in net interest income is due to the lag in the repricing of certificates of deposits which mature throughout the twelve month period. | <sup>(1)</sup> The percentage change in this column represents net interest income of the Company for 12 months in a stable interest rate environment versus the net interest income in the various rate scenarios. Much of the increase in net interest income is due to the lag in the repricing of certificates of deposits which mature throughout the twelve month period. |
| <sup>(2)</sup> The percentage change in this column represents the net portfolio value of the Company in a stable interest rate environment versus the net portfolio value in the various rate scenarios. | <sup>(2)</sup> The percentage change in this column represents the net portfolio value of the Company in a stable interest rate environment versus the net portfolio value in the various rate scenarios. | <sup>(2)</sup> The percentage change in this column represents the net portfolio value of the Company in a stable interest rate environment versus the net portfolio value in the various rate scenarios. |

---

**Item 4. CONTROLS AND PROCEDURES.**

The Company's principal executive officer and principal financial officer have evaluated the effectiveness of the Company's "disclosure controls and procedures," as such term is defined in Rule 13a-15(e) or 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), as of the end of the period covered by this quarterly report. Based upon their evaluation, the principal executive officer and principal financial officer have concluded that the Company's disclosure controls and procedures are effective to ensure that information required to be disclosed by the Company in the reports filed or submitted by it under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms, and include controls and procedures designed to ensure that information required to be disclosed by the Company in such reports is accumulated and communicated to the Company's management, including its principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

There has not been any change in our internal control over financial reporting that occurred during the first quarter of 2026 that has materially affected, or is reasonably likely to materially affect, the Company's internal control over financial reporting.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 37

------

[**Table of Contents**](#toc)

**PART II** – **OTHER INFORMATION**

**Item 1. LEGAL PROCEEDINGS.**

From time to time, Bancorp and its subsidiaries are parties to litigation that arises in the ordinary course of business or otherwise is incidental to various aspects of its operations. Based upon information available to the Company and its review of any such litigation with counsel, management presently believes that the liability relating to such litigation, if any, would not be expected to have a material adverse impact on the Company's consolidated financial condition, results of operations or liquidity taken as a whole. The outcome of litigation and other legal and regulatory matters is inherently uncertain, however, and it is possible that one or more of the legal matters currently pending or threatened against the Company could have a material adverse effect on the Company's consolidated financial condition, results of operations or liquidity taken as a whole.

**Item 1A. RISK FACTORS.**

The Company is not aware of any material change to the risk factors as previously disclosed in Part I, Item 1A, of the Company's 2025 Form 10-K for the year ended December 31, 2025. In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the risk factors disclosed in Part I, Item 1A, of the Company's 2025 Form 10-K for the year ended December 31, 2025, which could materially and adversely affect the Company's business, financial condition, results of operations and stock price. The risk factors disclosed in the 2025 Form 10-K are not the only risks facing the Company. Additional risks and uncertainties, including those not presently known to the Company or that the Company presently believes not to be material, could also materially and adversely affect the Company's business, financial condition, and results of operations and stock price.

**Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.**

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Issuer Purchases of Equity Securities** | **Issuer Purchases of Equity Securities** | **Issuer Purchases of Equity Securities** | **Issuer Purchases of Equity Securities** | **Issuer Purchases of Equity Securities** |
| **Period** | **(a) Total Number of Shares Purchased** | **(b) Average Price Paid per Share (or Unit)** | **(c) Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs** | **(d) Maximum Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs** |
| (January 1, 2026 - January 31, 2026) | 160000 | $50.51 | 160000 | $4412356.25 |
| (February 1, 2026 - February 28, 2026) | 83499 | $52.84 | 83499 | $158.79 |
| (March 1, 2026 - March 31, 2026) | 0 | $- | 0 | $- |
| Total | 243499 | $51.31 | 243499 | $158.79 |

---

For a discussion of limitations on the payment of dividends, see "*Dividend Policy*" and "*Liquidity*" under Part I—Item 2— "Management's Discussion and Analysis of Financial Condition and Results of Operations."

**Item 3.**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **DEFAULTS UPON SENIOR SECURITIES.**

Not applicable.

**Item 4.**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **MINE SAFETY DISCLOSURES.**

Not applicable.

**Item *5.***&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **OTHER INFORMATION.**

During the quarter ended *March 31, 2026*, no director or Section *16* officer adopted or terminated any Rule *10b5*-*1* trading arrangements or non-Rule *10b5*-*1* trading arrangements, as defined under Item *408*(a) of Regulation S-K.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 38

------

[**Table of Contents**](#toc)

**Item 6.**&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **EXHIBITS.**

---

| | |
|:---|:---|
| Exhibit 3.1 | [Restated Certificate of Incorporation. Previously filed with the Securities and Exchange Commission on February 29, 2016, as an exhibit to Bancorp's Annual Report on Form 10-K for the year ended December 31, 2015, and incorporated herein by reference.](http://www.sec.gov/Archives/edgar/data/861842/000143774916026345/ex3-1.htm) |
| Exhibit 3.1.1 | [Amendment to Restated Certificate of Incorporation. Previously filed with the Securities and Exchange Commission on February 29, 2016, as an exhibit to Bancorp's Annual Report on Form 10-K for the year ended December 31, 2015, and incorporated herein by reference.](http://www.sec.gov/Archives/edgar/data/861842/000143774916026345/ex3-11.htm) |
| Exhibit 3.2 | [Amended and Restated Bylaws, effective February 16, 2017. Previously filed with the Securities and Exchange Commission on February 17, 2017, as an exhibit to the Bancorp's Current Report on Form 8-K and incorporated herein by reference.](http://www.sec.gov/Archives/edgar/data/861842/000143774917002778/ex3-1.htm) |
| Exhibit 3.3 | [Certificate of Designation of Series A Junior Participating Preferred Stock. Previously filed with the Securities and Exchange Commission on February 28, 2012, as an exhibit to the Bancorp's Annual Report on Form 10-K for the year ended December 31, 2011, and incorporated herein by reference.](http://www.sec.gov/Archives/edgar/data/861842/000119312512082651/d260725dex33.htm) |
| Exhibit 3.4 | [Certificate of Designation of Fixed Rate Cumulative Perpetual Preferred Stock, Series B. Previously filed with the Securities and Exchange Commission on March 3, 2014, as an exhibit to the Bancorp's Annual Report on Form 10-K for the year ended December 31, 2013 and incorporated herein by reference.](http://www.sec.gov/Archives/edgar/data/861842/000143774914003147/ex3-4.htm) |
| Exhibit 31.1+ | [Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](ex_935153.htm) |
| Exhibit 31.2+ | [Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.](ex_935154.htm) |
| Exhibit 32.1++ | [Certification of the Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](ex_935155.htm) |
| Exhibit 32.2++ | [Certification of the Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.](ex_935156.htm) |
| Exhibit 101.INS | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document\* |
| Exhibit 101.SCH | Inline XBRL Taxonomy Extension Schema Document\* |
| Exhibit 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document\* |
| Exhibit 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document\* |
| Exhibit 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document\* |
| Exhibit 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document\* |
| Exhibit 104 | Cover Page Interactive Data File – the cover page XBRL tags are embedded within the Inline XBRL document\* |

---

____________________

---

| | |
|:---|:---|
| + | Filed herewith. |

---

---

| | |
|:---|:---|
| ++ | Furnished herewith. |

---

\* Filed electronically herewith.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 39

------

[**Table of Contents**](#toc)

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | |
|:---|:---|
|  | <u>Cathay General Bancorp</u> |
|  | (Registrant) |
| Date: May 8, 2026 | |
|  | /s/ Chang M. Liu |
|  | Chang M. Liu |
|  | President and Chief Executive Officer |

---

---

| | |
|:---|:---|
| Date: May 8, 2026 | |
|  | /s/ Albert J. Wang |
|  | Albert J. Wang |
|  | Executive Vice President and |
|  | Chief Financial Officer |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 40

## Exhibit 31.1

**Exhibit 31.1** 

I, Chang M. Liu, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this quarterly report on Form 10-Q of Cathay General Bancorp;

&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's Board of Directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
|  | /s/ Chang M. Liu |
|  | Chang M. Liu |
|  | President and Chief Executive Officer |
| Date: May 8, 2026 |  |

---

## Exhibit 31.2

**Exhibit 31.2** 

I, Albert J. Wang, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;1. I have reviewed this quarterly report on Form 10-Q of Cathay General Bancorp;

&nbsp;&nbsp;&nbsp;&nbsp;2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

&nbsp;&nbsp;&nbsp;&nbsp;3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

&nbsp;&nbsp;&nbsp;&nbsp;4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

&nbsp;&nbsp;&nbsp;&nbsp;5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's Board of Directors (or persons performing the equivalent functions):

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
|  | /s/ Albert J. Wang |
|  | Albert J. Wang |
|  | Executive Vice President and |
|  | Chief Financial Officer |
| Date: May 8, 2026 |  |

---

## Exhibit 32.1

**Exhibit 32.1** 

**CEO CERTIFICATION PURSUANT TO** 

**18 U.S.C. SECTION 1350,** 

**AS ADOPTED PURSUANT TO** 

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002** 

In connection with the Quarterly Report of Cathay General Bancorp (the "Company") on Form 10-Q for the period ended March 31, 2026 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Chang M. Liu, chief executive officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | |
|:---|:---|
|  | /s/ Chang M. Liu |
|  | Chang M. Liu |
|  | President and Chief Executive Officer |
| Date: May 8, 2026 |  |

---

## Exhibit 32.2

**Exhibit 32.2** 

**CFO CERTIFICATION PURSUANT TO** 

**18 U.S.C. SECTION 1350,** 

**AS ADOPTED PURSUANT TO** 

**SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002** 

In connection with the Quarterly Report of Cathay General Bancorp (the "Company") on Form 10-Q for the period ended March 31, 2026 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Heng W. Chen, chief financial officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

---

| | |
|:---|:---|
|  | /s/ Albert J. Wang |
|  | Albert J. Wang |
|  | Executive Vice President and |
|  | Chief Financial Officer |
| Date: May 8, 2026 |  |

---